Heat O
- O
shock O
response O
and O
its O
contribution O
to O
thermotolerance O
of O
the O
nitrogen O
- O
fixing O
cyanobacterium O
Anabaena Bacteria_B
sp Bacteria_I
. Bacteria_I
 Bacteria_I
strain Bacteria_I
L Bacteria_I
- Bacteria_I
31 O
. O

Compared O
to O
Escherichia Bacteria_B
coli Bacteria_I
, O
the O
nitrogen O
- O
fixing O
soil Habitat_B
cyanobacterium O
Anabaena Bacteria_B
sp Bacteria_I
. Bacteria_I
 Bacteria_I
strain Bacteria_I
L Bacteria_I
- Bacteria_I
31 O
exhibited O
significantly O
superior O
abilities O
to O
survive O
prolonged O
and O
continuous O
heat O
stress O
and O
recover O
therefrom O
. O

Temperature O
upshift O
induced O
the O
synthesis O
of O
heat O
- O
shock O
proteins O
of O
similar O
molecular O
mass O
in O
the O
two O
microbes O
. O

However O
, O
in O
Anabaena Bacteria_B
sp Bacteria_I
. Bacteria_I
 Bacteria_I
strain Bacteria_I
L Bacteria_I
- Bacteria_I
31 O
the O
heat O
- O
shock O
proteins O
( O
particularly O
the O
GroEL O
proteins O
) O
were O
synthesised O
throughout O
the O
stress O
period O
, O
were O
much O
more O
stable O
and O
accumulated O
during O
heat O
stress O
. O

In O
contrast O
, O
in O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
the O
heat O
- O
shock O
proteins O
were O
transiently O
synthesised O
, O
quickly O
turned O
over O
and O
did O
not O
accumulate O
. O

Nitrogenase O
activity O
of O
Anabaena Bacteria_B
cells O
of O
sp O
. O

strain O
L Bacteria_B
- Bacteria_I
31 Bacteria_I
continuously O
exposed O
to O
heat O
stress O
for O
7 O
days O
rapidly O
recovered O
from O
thermal O
injury O
, O
although O
growth O
recovery O
was O
delayed O
. O

Exposure O
of O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
cells O
to O
> O
4 O
. O
5 O
h O
of O
heat O
stress O
resulted O
in O
a O
complete O
loss O
of O
viability O
and O
the O
ability O
to O
recover O
. O

Marked O
differences O
in O
the O
synthesis O
, O
stability O
and O
accumulation O
of O
heat O
- O
shock O
proteins O
appear O
to O
distinguish O
these O
bacteria O
in O
their O
thermotolerance O
and O
recovery O
from O
heat O
stress O
. O

Is O
fidaxomicin O
worth O
the O
cost O
? O

An O
economic O
analysis O
. O

In O
May O
2011 O
, O
the O
Food O
and O
Drug O
Administration O
approved O
fidaxomicin O
for O
the O
treatment O
of O
Clostridium Bacteria_B
difficile Bacteria_I
infection O
( O
CDI O
) O
. O

It O
has O
been O
found O
to O
be O
noninferior O
to O
vancomycin O
; O
however O
, O
its O
cost O
- O
effectiveness O
for O
the O
treatment O
of O
CDI O
remains O
undetermined O
. O

We O
developed O
a O
decision O
analytic O
simulation O
model O
to O
determine O
the O
economic O
value O
of O
fidaxomicin O
for O
CDI O
treatment O
from O
the O
third O
- O
party O
payer O
perspective O
. O

We O
looked O
at O
CDI O
treatment O
in O
these O
3 O
cases O
: O
( O
1 O
) O
no O
fidaxomicin O
, O
( O
2 O
) O
only O
fidaxomicin O
, O
and O
( O
3 O
) O
fidaxomicin O
based O
on O
strain O
typing O
results O
. O

The O
incremental O
cost O
- O
effectiveness O
ratio O
for O
fidaxomicin O
based O
on O
screening O
given O
current O
conditions O
was O
> O
$ O
43 O
. O
7 O
million O
per O
quality O
- O
adjusted O
life O
- O
year O
and O
using O
only O
fidaxomicin O
was O
dominated O
( O
ie O
, O
more O
costly O
and O
less O
effective O
) O
by O
the O
other O
2 O
treatment O
strategies O
explored O
. O

The O
fidaxomicin O
strategy O
tended O
to O
remain O
dominated O
, O
even O
at O
lower O
costs O
. O

With O
approximately O
50 O
% O
of O
CDI O
due O
to O
the O
NAP1 O
/ O
BI O
/ O
027 O
strain O
, O
a O
course O
of O
fidaxomicin O
would O
need O
to O
cost O
≤ O
$ O
150 O
to O
be O
cost O
- O
effective O
in O
the O
treatment O
of O
all O
CDI O
cases O
and O
between O
$ O
160 O
and O
$ O
400 O
to O
be O
cost O
- O
effective O
for O
those O
with O
a O
non O
- O
NAP1 O
/ O
BI O
/ O
027 O
strain O
( O
ie O
, O
treatment O
based O
on O
strain O
typing O
) O
. O

Given O
the O
current O
cost O
and O
NAP1 O
/ O
BI O
/ O
027 O
accounting O
for O
approximately O
50 O
% O
of O
isolates O
, O
using O
fidaxomicin O
as O
a O
first O
- O
line O
treatment O
for O
CDI O
is O
not O
cost O
- O
effective O
. O

However O
, O
typing O
and O
treatment O
with O
fidaxomicin O
based O
on O
strain O
may O
be O
more O
promising O
depending O
on O
the O
costs O
of O
fidaxomicin O
. O

The O
effect O
of O
Artemisia Habitat_B
annua Habitat_I
on O
broiler Habitat_B
performance O
, O
on O
intestinal Habitat_B
microbiota O
and O
on O
the O
course O
of O
a O
Clostridium Bacteria_B
perfringens Bacteria_I
infection O
applying O
a O
necrotic O
enteritis O
disease O
model O
. O

The O
aerial Habitat_B
parts Habitat_I
of Habitat_I
the Habitat_I
plant Habitat_I
Artemisia Habitat_I
annua Habitat_I
contain O
essential Habitat_B
oils Habitat_I
having O
antimicrobial O
properties O
against O
Clostridium Bacteria_B
perfringens Bacteria_I
Type Bacteria_I
A Bacteria_I
, O
the O
causal O
agent O
for O
necrotic O
enteritis O
in O
broilers Habitat_B
. O

In O
two O
experiments O
, O
the O
influence O
of O
increasing O
dietary O
concentrations O
of O
dried Habitat_B
A Habitat_I
. Habitat_I
annua Habitat_I
leaves Habitat_I
( O
0 O
, O
5 O
, O
10 O
and O
20 O
g O
/ O
kg O
) O
and O
n Habitat_B
- Habitat_I
hexane Habitat_I
extract Habitat_I
from Habitat_I
fresh Habitat_I
A Habitat_I
. Habitat_I
annua Habitat_I
leaves Habitat_I
( O
0 O
, O
125 O
, O
250 O
and O
500 O
mg O
/ O
kg O
) O
on O
broiler Habitat_B
performance O
was O
investigated O
. O

Dried Habitat_B
plant Habitat_I
material Habitat_I
decreased O
feed Habitat_B
intake O
and O
body Habitat_B
weight O
in O
a O
dose O
- O
dependent O
manner O
, O
and O
10 O
and O
20 O
g O
/ O
kg O
diet O
tended O
to O
improve O
the O
feed Habitat_B
conversion O
ratio O
. O

The O
n O
- O
hexane O
extract O
also O
reduced O
feed Habitat_B
intake O
, O
but O
broiler Habitat_B
weight O
tended O
to O
decrease O
only O
at O
the O
highest O
dietary O
concentration O
. O

The O
feed Habitat_B
conversion O
ratio O
tended O
to O
improve O
when O
birds Habitat_B
received O
250 O
and O
500 O
mg O
/ O
kg O
n Habitat_B
- Habitat_I
hexane Habitat_I
extract Habitat_I
. O

In O
a O
third O
experiment O
, O
a O
necrotic O
enteritis O
disease O
model O
was O
applied O
to O
investigate O
the O
effect O
of O
the O
dietary O
addition O
of O
dried Habitat_B
A Habitat_I
. Habitat_I
annua Habitat_I
leaves Habitat_I
( O
10 O
g O
/ O
kg O
on O
top O
) O
or O
n Habitat_B
- Habitat_I
hexane Habitat_I
extract Habitat_I
of Habitat_I
A Habitat_I
. Habitat_I
annua Habitat_I
( O
250 O
mg O
/ O
kg O
) O
on O
the O
severity O
of O
the O
disease O
in O
broilers Habitat_B
. O

The O
addition O
of O
n Habitat_B
- Habitat_I
hexane Habitat_I
extract Habitat_I
reduced O
the O
intestinal Habitat_B
C Bacteria_B
. Bacteria_I
perfringens Bacteria_I
numbers O
and O
the O
severity O
of O
the O
disease O
- O
related O
small Habitat_B
intestinal Habitat_I
lesions Habitat_I
. O

Over O
the O
infection O
period O
from O
day O
17 O
to O
day O
27 O
, O
birds Habitat_B
supplemented Habitat_I
with Habitat_I
the Habitat_I
n Habitat_I
- Habitat_I
hexane Habitat_I
extract Habitat_I
gained O
more O
weight O
than O
both O
the O
challenged Habitat_B
control Habitat_I
birds Habitat_I
and O
birds Habitat_B
receiving Habitat_I
dried Habitat_I
plant Habitat_I
material Habitat_I
. O

The O
results O
indicate O
that O
n Habitat_B
- Habitat_I
hexane Habitat_I
extracts Habitat_I
derived Habitat_I
from Habitat_I
A Habitat_I
. Habitat_I
annua Habitat_I
can O
modulate O
the O
course O
of O
necrotic O
enteritis O
and O
compensate O
to O
a O
certain O
extent O
for O
the O
disease O
- O
associated O
weight O
losses O
. O

XopC O
and O
XopJ O
, O
two O
novel O
type O
III O
effector O
proteins O
from O
Xanthomonas Bacteria_B
campestris Bacteria_I
pv Bacteria_I
. Bacteria_I
 Bacteria_I
vesicatoria O
. O

Pathogenicity O
of O
the O
gram O
- O
negative O
plant Habitat_B
pathogen O
Xanthomonas Bacteria_B
campestris Bacteria_I
pv Bacteria_I
. Bacteria_I
 Bacteria_I
vesicatoria O
depends O
on O
a O
type O
III O
secretion O
( O
TTS O
) O
system O
which O
translocates O
bacterial O
effector O
proteins O
into O
the O
plant Habitat_B
cell Habitat_I
. O

Previous O
transcriptome O
analysis O
identified O
a O
genome O
- O
wide O
regulon O
of O
putative O
virulence O
genes O
that O
are O
coexpressed O
with O
the O
TTS O
system O
. O

In O
this O
study O
, O
we O
characterized O
two O
of O
these O
genes O
, O
xopC O
and O
xopJ O
. O

Both O
genes O
encode O
Xanthomonas Bacteria_B
outer O
proteins O
( O
Xops O
) O
that O
were O
shown O
to O
be O
secreted O
by O
the O
TTS O
system O
. O

In O
addition O
, O
type O
III O
- O
dependent O
translocation O
of O
both O
proteins O
into O
the O
plant Habitat_B
cell Habitat_I
was O
demonstrated O
using O
the O
AvrBs3 O
effector O
domain O
as O
a O
reporter O
. O

XopJ O
belongs O
to O
the O
AvrRxv O
/ O
YopJ O
family O
of O
effector O
proteins O
from O
plant Habitat_B
and O
animal Habitat_B
pathogenic O
bacteria O
. O

By O
contrast O
, O
XopC O
does O
not O
share O
significant O
homology O
to O
proteins O
in O
the O
database O
. O

Sequence O
analysis O
revealed O
that O
the O
xopC O
locus O
contains O
several O
features O
that O
are O
reminiscent O
of O
pathogenicity O
islands O
. O

Interestingly O
, O
the O
xopC O
region O
is O
flanked O
by O
62 O
- O
bp O
inverted O
repeats O
that O
are O
also O
associated O
with O
members O
of O
the O
Xanthomonas Bacteria_B
avrBs3 O
effector O
family O
. O

Besides O
xopC O
, O
a O
second O
gene O
of O
the O
locus O
, O
designated O
hpaJ O
, O
was O
shown O
to O
be O
coexpressed O
with O
the O
TTS O
system O
. O

hpaJ O
encodes O
a O
protein O
with O
similarity O
to O
transglycosylases O
and O
to O
the O
Pseudomonas Bacteria_B
syringae Bacteria_I
pv Bacteria_I
. Bacteria_I
 Bacteria_I
maculicola O
protein O
HopPmaG O
. O

HpaJ O
secretion O
and O
translocation O
by O
the O
X Bacteria_B
. Bacteria_I
campestris Bacteria_I
pv Bacteria_I
. Bacteria_I
 Bacteria_I
vesicatoria O
TTS O
system O
was O
not O
detectable O
, O
which O
is O
consistent O
with O
its O
predicted O
Sec O
signal O
and O
a O
putative O
function O
as O
transglycosylase O
in O
the O
bacterial O
periplasm O
. O

Preliminary O
X O
- O
ray O
crystallographic O
analysis O
of O
β O
- O
carbonic O
anhydrase O
psCA3 O
from O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
. O

Pseudomonas Bacteria_B
aeruginosa Bacteria_I
is O
a O
Gram O
- O
negative O
bacterium O
that O
causes O
life O
- O
threatening O
infections O
in O
susceptible Habitat_B
individuals Habitat_I
and O
is O
resistant O
to O
most O
clinically O
available O
antimicrobials O
. O

Genomic O
and O
proteomic O
studies O
have O
identified O
three O
genes O
, O
pa0102 O
, O
pa2053 O
and O
pa4676 O
, O
in O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
PAO1 Bacteria_I
encoding O
three O
functional O
β O
- O
carbonic O
anhydrases O
( O
β O
- O
CAs O
) O
: O
psCA1 O
, O
psCA2 O
and O
psCA3 O
, O
respectively O
. O

These O
β O
- O
CAs O
could O
serve O
as O
novel O
antimicrobial O
drug O
targets O
for O
this O
pathogen O
. O

X O
- O
ray O
crystallographic O
structural O
studies O
have O
been O
initiated O
to O
characterize O
the O
structure O
and O
function O
of O
these O
proteins O
. O

This O
communication O
describes O
the O
production O
of O
two O
crystal O
forms O
( O
A O
and O
B O
) O
of O
β O
- O
CA O
psCA3 O
. O

Form O
A O
diffracted O
to O
a O
resolution O
of O
2 O
. O
9 O
Å O
; O
it O
belonged O
to O
space O
group O
P212121 O
, O
with O
unit O
- O
cell O
parameters O
a O
= O
81 O
. O
9 O
, O
b O
= O
84 O
. O
9 O
, O
c O
= O
124 O
. O
2 O
Å O
, O
and O
had O
a O
calculated O
Matthews O
coefficient O
of O
2 O
. O
23 O
Å³ O
Da O
⁻ O
¹ O
assuming O
four O
molecules O
in O
the O
crystallographic O
asymmetric O
unit O
. O

Form O
B O
diffracted O
to O
a O
resolution O
of O
3 O
. O
0 O
Å O
; O
it O
belonged O
to O
space O
group O
P21212 O
, O
with O
unit O
- O
cell O
parameters O
a O
= O
69 O
. O
9 O
, O
b O
= O
77 O
. O
7 O
, O
c O
= O
88 O
. O
5 O
Å O
, O
and O
had O
a O
calculated O
Matthews O
coefficient O
of O
2 O
. O
48 O
Å³ O
Da O
⁻ O
¹ O
assuming O
two O
molecules O
in O
the O
crystallographic O
asymmetric O
unit O
. O

Preliminary O
molecular O
- O
replacement O
solutions O
have O
been O
determined O
with O
the O
PHENIX O
AutoMR O
wizard O
and O
refinement O
of O
both O
crystal O
forms O
is O
currently O
in O
progress O
. O

Clinical O
factors O
associated O
with O
development O
of O
severe O
- O
complicated O
Clostridium Bacteria_B
difficile Bacteria_I
infection O
. O

Clostridium Bacteria_B
difficile Bacteria_I
infection O
( O
CDI O
) O
can O
cause O
life O
- O
threatening O
complications O
. O

Severe O
- O
complicated O
CDI O
is O
characterized O
by O
hypotension O
, O
shock O
, O
sepsis O
, O
ileus O
, O
megacolon O
, O
and O
colon Habitat_B
perforation O
. O

We O
created O
a O
model O
to O
identify O
clinical O
factors O
associated O
with O
severe O
- O
complicated O
CDI O
. O

We O
analyzed O
data O
from O
1446 O
inpatient Habitat_B
cases Habitat_I
of Habitat_I
CDI Habitat_I
( Habitat_I
48 Habitat_I
. Habitat_I
6 Habitat_I
% Habitat_I
female Habitat_I
; Habitat_I
median Habitat_I
age Habitat_I
, Habitat_I
62 Habitat_I
. Habitat_I
5 Habitat_I
years Habitat_I
; Habitat_I
range Habitat_I
, Habitat_I
0 Habitat_I
. Habitat_I
1 Habitat_I
- Habitat_I
103 Habitat_I
. Habitat_I
7 Habitat_I
years Habitat_I
) Habitat_I
at O
the O
Mayo Habitat_B
Clinic Habitat_I
from O
June O
28 O
, O
2007 O
, O
to O
June O
25 O
, O
2010 O
. O

Patients Habitat_B
with Habitat_I
severe Habitat_I
- Habitat_I
complicated Habitat_I
CDI Habitat_I
( O
n O
  O
= O
487 O
) O
were O
identified O
as O
those O
who O
required O
admission O
to O
the O
intensive Habitat_B
care Habitat_I
unit Habitat_I
or O
colectomy O
, O
or O
died O
, O
within O
30 O
days O
of O
CDI O
diagnosis O
. O

Logistic O
regression O
models O
were O
used O
to O
identify O
variables O
that O
were O
independently O
associated O
with O
the O
occurrence O
of O
severe O
- O
complicated O
CDI O
in O
2 O
cohorts O
. O

One O
cohort O
comprised O
all O
hospitalized Habitat_B
patients Habitat_I
; O
the O
other O
comprised O
a O
subset O
of O
these O
inpatients Habitat_B
who O
were O
residents O
of O
Olmsted O
County O
, O
Minnesota O
to O
assess O
the O
association O
of O
comorbid O
conditions O
with O
the O
development O
of O
severe O
- O
complicated O
infection O
in O
a O
population Habitat_B
- Habitat_I
based Habitat_I
cohort Habitat_I
. O

The O
linear O
combinations O
of O
variables O
identified O
by O
using O
logistic O
regression O
models O
provided O
scores O
to O
predict O
the O
risk O
of O
developing O
severe O
- O
complicated O
CDI O
. O

In O
a O
multivariable O
model O
that O
included O
all O
inpatients Habitat_B
, O
increasing O
age O
, O
leukocyte Habitat_B
count O
> O
15 O
  O
× O
  O
10 O
( O
9 O
) O
/ O
L O
, O
increase O
in O
serum Habitat_B
level O
of O
creatinine O
> O
1 O
. O
5 O
- O
fold O
from O
baseline O
, O
and O
use O
of O
proton O
pump O
inhibitors O
or O
narcotic O
medications O
were O
independently O
associated O
with O
severe O
- O
complicated O
CDI O
. O

In O
the O
secondary O
analysis O
, O
which O
included O
only O
patients Habitat_B
from O
Olmsted O
County O
, O
comorbid O
conditions O
were O
not O
significantly O
associated O
with O
severe O
- O
complicated O
CDI O
. O

Older O
age O
, O
high O
numbers O
of O
leukocytes Habitat_B
in O
blood Habitat_B
samples Habitat_I
, O
an O
increased O
serum Habitat_B
level O
of O
creatinine O
, O
gastric Habitat_B
acid Habitat_I
suppression O
, O
and O
use O
of O
narcotic O
medications O
were O
independently O
associated O
with O
development O
of O
severe O
- O
complicated O
CDI O
in O
hospitalized Habitat_B
patients Habitat_I
. O

Early O
aggressive O
monitoring O
and O
intervention O
could O
improve O
outcomes O
. O

Isolation O
and O
properties O
of O
extracellular O
alkaline O
phosphatase O
from O
Bacillus Bacteria_B
intermedius Bacteria_I
. O

Alkaline O
phosphatase O
( O
APase O
) O
was O
isolated O
from O
the O
culture O
liquid O
of O
the O
streptomycin O
- O
resistant O
strain O
of O
Bacillus Bacteria_B
intermedius Bacteria_I
S3 Bacteria_I
- Bacteria_I
19 Bacteria_I
and O
purified O
as O
a O
homogeneous O
preparation O
by O
ion O
- O
exchange O
chromatography O
and O
FPLC O
. O

Electrophoresis O
and O
gel O
- O
filtration O
revealed O
that O
the O
active O
enzyme O
is O
a O
monomer O
with O
molecular O
weight O
of O
46 O
- O
47 O
kD O
. O

The O
enzyme O
possessed O
phosphomonoesterase O
and O
phosphodiesterase O
activities O
with O
maximal O
levels O
at O
pH O
9 O
. O
5 O
and O
55 O
degreesC O
and O
was O
stable O
until O
60 O
degreesC O
at O
pH O
8 O
. O
0 O
- O
10 O
. O
0 O
. O

The O
isolated O
APase O
exhibits O
a O
broad O
specificity O
towards O
a O
wide O
variety O
of O
substrates O
. O

The O
effect O
of O
divalent O
metal O
ions O
and O
other O
reagents O
on O
its O
catalytic O
activities O
was O
studied O
. O

It O
was O
concluded O
that O
alkaline O
phosphatase O
of O
B Bacteria_B
. Bacteria_I
intermedius Bacteria_I
is O
similar O
to O
the O
secreted O
alkaline O
phosphatases O
from O
other O
Bacillus Bacteria_B
species O
in O
its O
physicochemical O
and O
catalytic O
properties O
. O

Genotyping O
by O
restriction O
endonuclease O
analysis O
compared O
to O
phenotyping O
by O
antibiogram O
for O
typing O
methicillin O
- O
resistant O
Staphylococcus Bacteria_B
aureus Bacteria_I
strains O
colonizing O
patients Habitat_B
in O
a O
nursing Habitat_B
home Habitat_I
. O

To O
assist O
in O
defining O
patterns O
of O
methicillin O
- O
resistant O
Staphylococcus Bacteria_B
aureus Bacteria_I
( O
MRSA Bacteria_B
) O
colonization O
in O
a O
skilled Habitat_B
nursing Habitat_I
facility Habitat_I
( O
SNF Habitat_B
) O
, O
we O
compared O
genotyping O
by O
field O
- O
inversion O
gel O
electrophoresis O
( O
FIGE O
) O
restriction O
endonuclease O
digestion O
analysis O
( O
REA O
) O
with O
phenotyping O
by O
antibiogram O
for O
defining O
strain O
relatedness O
among O
MRSA Bacteria_B
isolates O
from O
SNF Habitat_B
patients Habitat_I
. O

Prospective O
screening O
culture O
surveillance O
for O
MRSA Bacteria_B
among O
patients Habitat_B
in O
a O
community Habitat_B
SNF Habitat_I
. O

Nares Habitat_B
and O
stool Habitat_B
swab O
cultures O
were O
obtained O
from O
newly O
admitted O
patients Habitat_B
and O
from O
all O
patients Habitat_B
quarterly O
. O

MRSA Bacteria_B
were O
isolated O
by O
oxacillin Habitat_B
screening Habitat_I
agar Habitat_I
. O

Antibiograms O
were O
determined O
by O
the O
disk O
- O
diffusion O
method O
, O
and O
genotyping O
was O
by O
FIGE O
REA O
. O

It O
was O
shown O
that O
, O
among O
isolates O
with O
the O
same O
genotypes O
, O
many O
had O
different O
antibiograms O
; O
among O
isolates O
with O
the O
same O
antibiograms O
, O
many O
had O
different O
genotypes O
; O
and O
the O
discriminatory O
indices O
for O
isolates O
of O
MRSA Bacteria_B
by O
FIGE O
REA O
and O
by O
antibiogram O
were O
0 O
. O
56 O
and O
0 O
. O
78 O
, O
respectively O
. O

Our O
study O
demonstrated O
that O
, O
in O
patients Habitat_B
from Habitat_I
one Habitat_I
SNF Habitat_I
, O
genotyping O
by O
FIGE O
REA O
identified O
two O
prevalent O
REA O
DNA O
types O
, O
but O
with O
variability O
of O
antibiogram O
patterns O
within O
each O
DNA O
type O
; O
the O
antibiogram O
also O
identified O
prevalent O
patterns O
with O
variability O
of O
REA O
DNA O
type O
within O
each O
antibiogram O
pattern O
. O

The O
discriminatory O
index O
of O
antibiograms O
alone O
, O
or O
of O
genotypes O
alone O
as O
determined O
by O
FIGE O
REA O
, O
was O
poor O
for O
strains O
of O
MRSA Bacteria_B
isolated O
from O
the O
SNF Habitat_B
patients Habitat_I
in O
our O
study O
. O

Flow O
cytometric O
measurement O
of O
neutrophil Habitat_B
alkaline O
phosphatase O
before O
and O
during O
initiation O
of O
an O
induced O
Escherichia Bacteria_B
coli Bacteria_I
mastitis O
in O
cattle Habitat_B
. O

In O
12 O
healthy Habitat_B
cows Habitat_I
, O
neutrophil Habitat_B
alkaline O
phosphatase O
( O
NAP O
) O
activity O
was O
measured O
by O
flow O
cytometer O
before O
and O
during O
an O
experimentally O
induced O
Escherichia Bacteria_B
coli Bacteria_I
mastitis O
, O
to O
study O
the O
role O
and O
increase O
of O
NAP O
in O
Gram O
- O
negative O
bacterial O
infections O
. O

Percentage O
of O
neutrophils Habitat_B
containing O
alkaline O
phosphatase O
and O
intensity O
of O
NAP O
activity O
were O
measured O
. O

Preinfection O
percentage O
of O
neutrophils Habitat_B
with O
enzyme O
activity O
varied O
between O
64 O
. O
0 O
% O
and O
84 O
. O
4 O
% O
and O
the O
intensity O
of O
enzyme O
activity O
was O
low O
in O
all O
cows Habitat_B
. O

After O
induction O
of O
infection O
, O
percentage O
of O
neutrophils Habitat_B
with O
enzyme O
activity O
showed O
a O
significant O
decrease O
on O
day O
1 O
followed O
by O
an O
significant O
increase O
on O
day O
3 O
. O

NAP O
intensity O
increased O
significantly O
on O
the O
second O
and O
third O
day O
after O
infection O
. O

This O
increase O
of O
intensity O
was O
significantly O
, O
positively O
correlated O
with O
the O
severity O
of O
infection O
. O

From O
this O
study O
we O
may O
conclude O
that O
variation O
in O
susceptibility O
to O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
mastitis O
could O
not O
be O
explained O
by O
preinfection O
NAP O
levels O
. O

The O
post O
- O
infection O
increase O
of O
NAP O
activity O
, O
that O
was O
found O
following O
an O
induced O
infection O
was O
more O
a O
result O
of O
increased O
enzyme O
intensity O
per O
neutrophil Habitat_B
, O
then O
from O
an O
increase O
of O
percentage O
neutrophils Habitat_B
with O
enzyme O
activity O
. O

Furthermore O
, O
a O
strong O
correlation O
was O
found O
between O
NAP O
intensity O
and O
severity O
of O
inflammation O
. O

There O
was O
evidence O
that O
the O
more O
severely Habitat_B
diseased Habitat_I
animals Habitat_I
showed O
stronger O
NAP O
intensity O
increase O
. O

Attachment O
of O
Escherichia Bacteria_B
coli Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
grown O
in O
tryptic Habitat_B
soy Habitat_I
broth Habitat_I
and O
nutrient Habitat_B
broth Habitat_I
to O
apple Habitat_B
and O
lettuce Habitat_B
surfaces O
as O
related O
to O
cell Habitat_B
hydrophobicity O
, O
surface O
charge O
, O
and O
capsule O
production O
. O

This O
study O
investigated O
the O
effect O
of O
growth O
in O
tryptic Habitat_B
soy Habitat_I
broth Habitat_I
( O
TSB Habitat_B
) O
and O
nutrient Habitat_B
broth Habitat_I
( O
NB Habitat_B
) O
on O
the O
ability O
Escherichia Bacteria_B
coli Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
to O
attach O
to O
lettuce Habitat_B
and O
apple Habitat_B
surfaces Habitat_I
. O

In O
addition O
, O
cell Habitat_B
surface O
hydrophobicity O
, O
charge O
and O
capsule O
production O
were O
determined O
on O
cells O
grown O
in O
these O
media O
. O

Cells O
grown O
in O
NB Habitat_B
attached O
less O
to O
lettuce Habitat_B
and O
apple Habitat_B
surfaces O
than O
did O
those O
grown O
in O
TSB Habitat_B
. O

TSB Habitat_B
, O
but O
not O
NB Habitat_B
, O
supported O
capsule O
production O
by O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
. O

Cells O
grown O
in O
TSB Habitat_B
were O
more O
hydrophilic O
than O
those O
grown O
in O
NB Habitat_B
. O

No O
difference O
was O
found O
in O
the O
electrokinetic O
properties O
of O
cells O
grown O
in O
these O
media O
. O

Electrostatic O
and O
hydrophobic O
interactions O
and O
surface O
proteins O
did O
not O
appear O
to O
play O
an O
important O
role O
in O
the O
attachment O
of O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
to O
these O
surfaces O
. O

Of O
the O
factors O
studied O
, O
only O
capsule O
production O
was O
associated O
with O
attachment O
ability O
. O

[ O
Value O
of O
protein O
array O
in O
the O
diagnosis O
of O
Helicobactor Bacteria_B
pylori Bacteria_I
infection O
in O
children Habitat_B
] O
. O

To O
study O
the O
value O
of O
multiple O
Helicobacter Bacteria_B
pylori Bacteria_I
( O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
) O
antibody O
detection O
by O
protein O
array O
in O
the O
diagnosis O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
in O
children Habitat_B
. O

Biopsy O
specimens O
obtained O
by O
gastroscopy O
from O
120 O
children Habitat_B
with Habitat_I
digestive Habitat_I
system Habitat_I
symptoms Habitat_I
were O
detected O
by O
rapid O
urease O
test O
( O
RUT O
) O
and O
modified O
Giemsa O
staining O
. O

Positivity O
in O
both O
RUT O
and O
Giemsa O
staining O
was O
the O
" O
gold O
criterion O
" O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
. O

Serum Habitat_B
samples Habitat_I
of Habitat_I
these Habitat_I
patients Habitat_I
were O
obtained O
and O
the O
antibodies O
against O
cytotoxin O
associated O
gene O
A O
protein O
( O
CagA O
) O
, O
vacuolating O
toxin O
A O
( O
VacA O
) O
, O
urease O
, O
heat O
shock O
protein O
60 O
( O
Hsp60 O
) O
and O
RdxA O
( O
nitroreductase O
) O
were O
detected O
by O
protein O
array O
technique O
. O

H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
was O
identified O
according O
to O
the O
" O
gold O
criterion O
" O
in O
60 O
children Habitat_B
. O

Compared O
with O
the O
" O
gold O
criterion O
" O
, O
the O
goodness O
of O
fit O
and O
the O
coefficient O
of O
contingency O
in O
the O
diagnosis O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
of O
the O
following O
four O
groups O
antibody O
detection O
were O
all O
statistically O
significant O
( O
P O
< O
0 O
. O
001 O
) O
: O
anti O
- O
Ure O
antibody O
alone O
, O
anti O
- O
Ure O
antibody O
combined O
with O
anti O
- O
CagA O
antibody O
, O
anti O
- O
Ure O
antibody O
combined O
with O
anti O
- O
VacA O
antibody O
and O
anti O
- O
Ure O
antibody O
combined O
with O
anti O
- O
CagA O
and O
anti O
- O
VacA O
antibody O
. O

The O
sensitivity O
, O
specificity O
and O
accuracy O
of O
the O
detection O
of O
anti O
- O
Ure O
antibody O
combined O
with O
anti O
- O
CagA O
antibody O
for O
the O
diagnosis O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
were O
81 O
. O
7 O
% O
, O
91 O
. O
7 O
% O
and O
86 O
. O
7 O
% O
, O
respectively O
. O

The O
antibody O
detection O
showed O
a O
high O
positive O
predictive O
value O
( O
90 O
. O
7 O
% O
) O
and O
a O
high O
negative O
predictive O
value O
( O
83 O
. O
3 O
% O
) O
. O

The O
antibody O
detection O
by O
protein O
array O
, O
especially O
the O
detection O
of O
anti O
- O
Ure O
antibody O
combined O
with O
anti O
- O
CagA O
antibody O
, O
is O
valuable O
in O
the O
diagnosis O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
. O

Non Bacteria_B
- Bacteria_I
O1 Bacteria_I
Vibrio Bacteria_I
cholerae Bacteria_I
bacteremia O
in O
patients Habitat_B
with Habitat_I
cirrhosis Habitat_I
: O
5 O
- O
yr O
experience O
from O
a O
single O
medical Habitat_B
center Habitat_I
. O

To O
assess O
the O
clinical O
features O
and O
susceptibility O
of O
cirrhotic Habitat_B
patients Habitat_I
to O
non Bacteria_B
- Bacteria_I
O1 Bacteria_I
Vibrio Bacteria_I
cholerae Bacteria_I
bacteremia O
and O
to O
provide O
our O
therapeutic O
experiences O
in O
this O
rare O
and O
high O
lethal O
infection O
. O

Twenty O
- O
eight O
blood Habitat_B
culture Habitat_I
isolates O
of O
non Bacteria_B
- Bacteria_I
O1 Bacteria_I
V Bacteria_I
. Bacteria_I
cholerae Bacteria_I
were O
identified O
by O
our O
clinical Habitat_B
microbiology Habitat_I
laboratory Habitat_I
between O
July O
1989 O
and O
June O
1994 O
. O

Patients Habitat_B
with Habitat_I
underlying Habitat_I
cirrhosis Habitat_I
and Habitat_I
the Habitat_I
aforementioned Habitat_I
bacteremia Habitat_I
were O
retrospectively O
reviewed O
. O

Twenty O
- O
one O
cirrhotic Habitat_B
patients Habitat_I
( Habitat_I
16 Habitat_I
male Habitat_I
, Habitat_I
five Habitat_I
female Habitat_I
; Habitat_I
mean Habitat_I
age Habitat_I
, Habitat_I
50 Habitat_I
. Habitat_I
9 Habitat_I
yr Habitat_I
; Habitat_I
range Habitat_I
28 Habitat_I
- Habitat_I
67 Habitat_I
yr Habitat_I
) Habitat_I
were O
identified O
and O
classified O
as O
Child Habitat_B
B Habitat_I
( O
6 O
cases O
) O
and O
Child Habitat_B
C Habitat_I
( O
15 O
cases O
) O
. O

Bacteremic O
episodes O
occurred O
most O
often O
from O
March O
to O
September O
. O

Seafood Habitat_B
ingestion O
( O
seven O
cases O
) O
and O
seawater Habitat_B
exposure O
( O
two O
cases O
) O
were O
risk O
factors O
, O
but O
nosocomial Habitat_B
infections O
were O
also O
noted O
in O
six O
cases O
. O

Presenting O
symptoms O
and O
signs O
included O
ascites Habitat_B
( O
95 O
. O
2 O
% O
) O
, O
fever O
( O
81 O
% O
) O
, O
abdominal Habitat_B
pain O
( O
52 O
. O
4 O
% O
) O
, O
diarrhea O
( O
33 O
. O
3 O
% O
) O
, O
and O
cellulitis O
with O
bullae O
formation O
( O
19 O
% O
) O
. O

Concurrent O
spontaneous O
bacterial O
peritonitis O
was O
determined O
in O
10 O
cases O
, O
seven O
with O
positive O
ascites Habitat_B
cultures O
. O

Antibiotic O
therapy O
( O
either O
cephalothin O
with O
gentamicin O
or O
ceftriaxone O
alone O
) O
cured O
most O
of O
the O
bacteremic O
episodes O
. O

The O
overall O
case O
- O
fatality O
rate O
was O
23 O
. O
8 O
% O
, O
but O
75 O
% O
of O
the O
deaths O
were O
observed O
in O
patients Habitat_B
with Habitat_I
skin Habitat_I
manifestation Habitat_I
. O

Patients Habitat_B
with Habitat_I
decompensated Habitat_I
cirrhosis Habitat_I
are O
susceptible O
to O
non Bacteria_B
- Bacteria_I
O1 Bacteria_I
V Bacteria_I
. Bacteria_I
cholerae Bacteria_I
bacteremia O
and O
should O
not O
ingest O
raw Habitat_B
seafood Habitat_I
or O
expose O
skin Habitat_B
wounds O
to O
salt Habitat_B
water Habitat_I
. O

A O
high O
index O
of O
suspicion O
and O
early O
administration O
of O
antibiotics O
may O
lower O
the O
mortality O
rate O
. O

Quorum O
- O
sensing O
regulation O
of O
adhesion O
in O
Serratia Bacteria_B
marcescens Bacteria_I
MG1 Bacteria_I
is O
surface O
dependent O
. O

Serratia Bacteria_B
marcescens Bacteria_I
is O
an O
opportunistic O
pathogen O
and O
a O
major O
cause O
of O
ocular Habitat_B
infections O
. O

In O
previous O
studies O
of O
S Bacteria_B
. Bacteria_I
marcescens Bacteria_I
MG1 Bacteria_I
, O
we O
showed O
that O
biofilm Habitat_B
maturation O
and O
sloughing O
were O
regulated O
by O
N O
- O
acyl O
homoserine O
lactone O
( O
AHL O
) O
- O
based O
quorum O
sensing O
( O
QS O
) O
. O

Because O
of O
the O
importance O
of O
adhesion O
in O
initiating O
biofilm Habitat_B
formation O
and O
infection O
, O
the O
primary O
goal O
of O
this O
study O
was O
to O
determine O
whether O
QS O
is O
important O
in O
adhesion O
to O
both O
abiotic O
and O
biotic Habitat_B
surfaces Habitat_I
, O
as O
assessed O
by O
determining O
the O
degree O
of O
attachment O
to O
hydrophilic Habitat_B
tissue Habitat_I
culture Habitat_I
plates Habitat_I
and O
human Habitat_B
corneal Habitat_I
epithelial Habitat_I
( Habitat_I
HCE Habitat_I
) Habitat_I
cells Habitat_I
. O

Our O
results O
demonstrate O
that O
while O
adhesion O
to O
the O
abiotic Habitat_B
surface Habitat_I
was O
AHL O
regulated O
, O
adhesion O
to O
the O
HCE Habitat_B
cell Habitat_I
biotic Habitat_I
surface Habitat_I
was O
not O
. O

Type O
I O
fimbriae O
were O
identified O
as O
the O
critical O
adhesin O
for O
non O
- O
QS O
- O
mediated O
attachment O
to O
the O
biotic Habitat_B
HCE Habitat_I
cell Habitat_I
surface Habitat_I
but O
played O
no O
role O
in O
adhesion O
to O
the O
abiotic Habitat_B
surface Habitat_I
. O

While O
we O
were O
not O
able O
to O
identify O
a O
single O
QS O
- O
regulated O
adhesin O
essential O
for O
attachment O
to O
the O
abiotic Habitat_B
surface Habitat_I
, O
four O
AHL O
- O
regulated O
genes O
involved O
in O
adhesion O
to O
the O
abiotic Habitat_B
surface Habitat_I
were O
identified O
. O

Interestingly O
, O
two O
of O
these O
genes O
, O
bsmA O
and O
bsmB O
, O
were O
also O
shown O
to O
be O
involved O
in O
adhesion O
to O
the O
biotic Habitat_B
surface Habitat_I
in O
a O
non O
- O
QS O
- O
controlled O
fashion O
. O

Therefore O
, O
the O
expression O
of O
these O
two O
genes O
appears O
to O
be O
cocontrolled O
by O
regulators O
other O
than O
the O
QS O
system O
for O
mediation O
of O
attachment O
to O
HCE Habitat_B
cells Habitat_I
. O

We O
also O
found O
that O
QS O
in O
S Bacteria_B
. Bacteria_I
marcescens Bacteria_I
regulates O
other O
potential O
cell O
surface O
adhesins O
, O
including O
exopolysaccharide O
and O
the O
outer O
membrane O
protein O
OmpX O
. O

We O
concluded O
that O
S Bacteria_B
. Bacteria_I
marcescens Bacteria_I
MG1 Bacteria_I
utilizes O
different O
regulatory O
systems O
and O
adhesins O
in O
attachment O
to O
biotic O
and O
abiotic Habitat_B
surfaces Habitat_I
and O
that O
QS O
is O
a O
main O
regulatory O
pathway O
in O
adhesion O
to O
an O
abiotic Habitat_B
surface Habitat_I
but O
not O
in O
adhesion O
to O
a O
biotic Habitat_B
surface Habitat_I
. O

Detection O
of O
Staphylococcus Bacteria_B
aureus Bacteria_I
including O
MRSA Bacteria_B
on O
environmental Habitat_B
surfaces Habitat_I
in Habitat_I
a Habitat_I
jail Habitat_I
setting Habitat_I
. O

We O
examined O
jail Habitat_B
environmental O
surfaces O
to O
explore O
whether O
they O
might O
serve O
as O
reservoirs O
of O
viable O
methicillin O
- O
resistant O
Staphylococcus Bacteria_B
aureus Bacteria_I
( O
MRSA Bacteria_B
) O
. O

We O
swabbed O
132 O
surfaces O
, O
inoculated O
primary Habitat_B
and Habitat_I
secondary Habitat_I
mannitol Habitat_I
salts Habitat_I
and O
oxacillin Habitat_B
- Habitat_I
resistant Habitat_I
screening Habitat_I
agar Habitat_I
, O
and O
used O
API O
tests O
to O
identify O
S Bacteria_B
. Bacteria_I
aureus Bacteria_I
and O
E O
- O
tests O
to O
determine O
methicillin O
/ O
oxacillin O
resistance O
. O

We O
recovered O
S Bacteria_B
. Bacteria_I
aureus Bacteria_I
from O
10 O
( O
7 O
. O
6 O
% O
) O
surfaces O
; O
eight O
( O
6 O
. O
1 O
% O
) O
isolates O
were O
MRSA Bacteria_B
. O

We O
ran O
pulsed O
- O
field O
gel O
electrophoresis O
on O
six O
resistant O
isolates O
and O
observed O
three O
patterns O
, O
one O
of O
which O
was O
identical O
to O
that O
identified O
in O
a O
previous O
study O
of O
inmates Habitat_B
' Habitat_I
nasal Habitat_I
specimens O
. O

Finding O
MRSA Bacteria_B
- O
contaminated O
surfaces O
on O
a O
variety O
of O
environmental O
surfaces O
in O
the O
absence O
of O
an O
overt O
outbreak O
emphasizes O
that O
correctional Habitat_B
facilities Habitat_I
should O
have O
protocols O
for O
environmental O
cleaning O
as O
a O
component O
of O
MRSA Bacteria_B
prevention O
. O

Structural O
basis O
for O
hemoglobin O
capture O
by O
Staphylococcus Bacteria_B
aureus Bacteria_I
cell O
- O
surface O
protein O
, O
IsdH O
. O

Pathogens O
must O
steal O
iron O
from O
their O
hosts O
to O
establish O
infection O
. O

In O
mammals Habitat_B
, O
hemoglobin O
( O
Hb O
) O
represents O
the O
largest O
reservoir O
of O
iron O
, O
and O
pathogens O
express O
Hb O
- O
binding O
proteins O
to O
access O
this O
source O
. O

Here O
, O
we O
show O
how O
one O
of O
the O
commonest O
and O
most O
significant O
human Habitat_B
pathogens O
, O
Staphylococcus Bacteria_B
aureus Bacteria_I
, O
captures O
Hb O
as O
the O
first O
step O
of O
an O
iron O
- O
scavenging O
pathway O
. O

The O
x O
- O
ray O
crystal O
structure O
of O
Hb O
bound O
to O
a O
domain O
from O
the O
Isd O
( O
iron O
- O
regulated O
surface O
determinant O
) O
protein O
, O
IsdH O
, O
is O
the O
first O
structure O
of O
a O
Hb O
capture O
complex O
to O
be O
determined O
. O

Surface O
mutations O
in O
Hb O
that O
reduce O
binding O
to O
the O
Hb O
- O
receptor O
limit O
the O
capacity O
of O
S Bacteria_B
. Bacteria_I
aureus Bacteria_I
to O
utilize O
Hb O
as O
an O
iron O
source O
, O
suggesting O
that O
Hb O
sequence O
is O
a O
factor O
in O
host O
susceptibility O
to O
infection O
. O

The O
demonstration O
that O
pathogens O
make O
highly O
specific O
recognition O
complexes O
with O
Hb O
raises O
the O
possibility O
of O
developing O
inhibitors O
of O
Hb O
binding O
as O
antibacterial O
agents O
. O

The O
lipid O
A O
from O
Vibrio Bacteria_B
fischeri Bacteria_I
lipopolysaccharide O
: O
a O
unique O
structure O
bearing O
a O
phosphoglycerol O
moiety O
. O

Vibrio Bacteria_B
fischeri Bacteria_I
, O
a O
bioluminescent O
marine Habitat_B
bacterium O
, O
exists O
in O
an O
exclusive O
symbiotic O
relationship O
with O
the O
Hawaiian Habitat_B
bobtail Habitat_I
squid Habitat_I
, O
Euprymna Habitat_B
scolopes Habitat_I
, O
whose O
light Habitat_B
organ Habitat_I
it O
colonizes O
. O

Previously O
, O
it O
has O
been O
shown O
that O
the O
lipopolysaccharide O
( O
LPS O
) O
or O
free O
lipid O
A O
of O
V Bacteria_B
. Bacteria_I
fischeri Bacteria_I
can O
trigger O
morphological O
changes O
in O
the O
juvenile Habitat_B
squid Habitat_I
' O
s O
light O
organ O
that O
occur O
upon O
colonization O
. O

To O
investigate O
the O
structural O
features O
that O
might O
be O
responsible O
for O
this O
phenomenon O
, O
the O
lipid O
A O
from O
V Bacteria_B
. Bacteria_I
fischeri Bacteria_I
ES114 O
LPS O
was O
isolated O
and O
characterized O
by O
multistage O
mass O
spectrometry O
( O
MS O
( O
n O
) O
) O
. O

A O
microheterogeneous Habitat_B
mixture Habitat_I
of Habitat_I
mono Habitat_I
- Habitat_I
and Habitat_I
diphosphorylated Habitat_I
diglucosamine Habitat_I
disaccharides Habitat_I
was O
observed O
with O
variable O
states O
of O
acylation O
ranging O
from O
tetra O
- O
to O
octaacylated O
forms O
. O

All O
lipid O
A O
species O
, O
however O
, O
contained O
a O
set O
of O
conserved O
primary O
acyl O
chains O
consisting O
of O
an O
N O
- O
linked O
C14 O
: O
0 O
( O
3 O
- O
OH O
) O
at O
the O
2 O
- O
position O
, O
an O
unusual O
N O
- O
linked O
C14 O
: O
1 O
( O
3 O
- O
OH O
) O
at O
the O
2 O
' O
- O
position O
, O
and O
two O
O O
- O
linked O
C12 O
: O
0 O
( O
3 O
- O
OH O
) O
fatty O
acids O
at O
the O
3 O
- O
and O
3 O
' O
- O
positions O
. O

The O
fatty O
acids O
found O
in O
secondary O
acylation O
were O
considerably O
more O
variable O
, O
with O
either O
a O
C12 O
: O
0 O
or O
C16 O
: O
1 O
at O
the O
2 O
- O
position O
, O
C14 O
: O
0 O
or O
C14 O
: O
0 O
( O
3 O
- O
OH O
) O
at O
the O
2 O
' O
- O
position O
, O
and O
C12 O
: O
0 O
or O
no O
substituent O
at O
the O
3 O
' O
- O
position O
. O

Most O
surprising O
was O
the O
presence O
of O
an O
unusual O
set O
of O
modifications O
at O
the O
secondary O
acylation O
site O
of O
the O
3 O
- O
position O
consisting O
of O
phosphoglycerol O
( O
GroP O
) O
, O
lysophosphatidic O
acid O
( O
GroP O
bearing O
C12 O
: O
0 O
, O
C16 O
: O
0 O
, O
or O
C16 O
: O
1 O
) O
, O
or O
phosphatidic O
acid O
( O
GroP O
bearing O
either O
C16 O
: O
0 O
+ O
C12 O
: O
0 O
or O
C16 O
: O
0 O
+ O
C16 O
: O
1 O
) O
. O

Given O
their O
unusual O
nature O
, O
it O
is O
possible O
that O
these O
features O
of O
the O
V Bacteria_B
. Bacteria_I
fischeri Bacteria_I
lipid O
A O
may O
underlie O
the O
ability O
of O
E Habitat_B
. Habitat_I
scolopes Habitat_I
to O
recognize O
its O
symbiotic O
partner O
. O

Evaluation O
of O
impermeant O
, O
DNA O
- O
binding O
dye O
fluorescence O
as O
a O
real O
- O
time O
readout O
of O
eukaryotic Habitat_B
cell Habitat_I
toxicity O
in O
a O
high O
throughput O
screening O
format O
. O

Interpretation O
of O
high O
throughput O
screening O
( O
HTS O
) O
data O
in O
cell Habitat_B
- O
based O
assays O
may O
be O
confounded O
by O
cytotoxic O
properties O
of O
screening O
compounds O
. O

Therefore O
, O
assessing O
cell Habitat_B
toxicity O
in O
real O
time O
during O
the O
HTS O
process O
itself O
would O
be O
highly O
advantageous O
. O

Here O
, O
we O
investigate O
the O
potential O
of O
putatively O
impermeant O
, O
fluorescent O
, O
DNA O
- O
binding O
dyes O
to O
give O
cell Habitat_B
toxicity O
readout O
during O
HTS O
. O

Amongst O
19 O
DNA O
- O
binding O
dyes O
examined O
, O
three O
classes O
were O
identified O
that O
were O
( O
1 O
) O
permeant O
, O
( O
2 O
) O
cytotoxic O
, O
or O
( O
3 O
) O
neither O
permeant O
nor O
cytotoxic O
during O
3 O
- O
day O
incubation O
with O
a O
macrophage Habitat_B
cell Habitat_I
line Habitat_I
. O

In O
the O
last O
class O
, O
four O
dyes O
( O
SYTOX O
Green O
, O
CellTox O
Green O
, O
GelGreen O
, O
and O
EvaGreen O
) O
gave O
highly O
robust O
cytotoxicity O
data O
in O
384 O
- O
well O
screening O
plates O
. O

As O
proof O
of O
principle O
, O
successful O
combination O
with O
a O
luminescence O
- O
based O
assay O
in O
HTS O
format O
was O
demonstrated O
. O

Here O
, O
both O
intracellular O
growth O
of O
Legionella Bacteria_B
pneumophila Bacteria_I
( O
luminescence O
) O
and O
host Habitat_B
cell Habitat_I
viability O
( O
SYTOX O
Green O
exclusion O
) O
were O
assayed O
in O
the O
same O
screening O
well O
. O

Incorporation O
of O
membrane O
- O
impermeant O
, O
DNA O
- O
binding O
, O
fluorescent O
dyes O
in O
HTS O
assays O
should O
prove O
useful O
by O
allowing O
evaluation O
of O
cytotoxicity O
in O
real O
time O
, O
eliminating O
reagent O
addition O
steps O
and O
effort O
associated O
with O
endpoint O
cell Habitat_B
viability O
analysis O
, O
and O
reducing O
the O
need O
for O
follow O
- O
up O
cytotoxicity O
screening O
. O

Unveiling O
molecular O
mechanisms O
of O
bacterial O
surface O
proteins O
: O
Streptococcus Bacteria_B
pneumoniae Bacteria_I
as O
a O
model O
organism O
for O
structural O
studies O
. O

Bacteria O
present O
a O
variety O
of O
molecules O
either O
on O
their O
surface O
or O
in O
a O
cell O
- O
free O
form O
. O

These O
molecules O
take O
part O
in O
numerous O
processes O
in O
the O
interactions O
with O
their O
host O
, O
with O
its O
tissues O
and O
other O
molecules O
. O

These O
molecules O
are O
essential O
to O
bacterial O
pathogenesis O
either O
during O
colonization O
or O
the O
spread O
/ O
invasion O
stages O
, O
and O
most O
are O
virulence O
factors O
. O

This O
review O
is O
focused O
on O
such O
molecules O
using O
Streptococcus Bacteria_B
pneumoniae Bacteria_I
, O
a O
Gram O
- O
positive O
bacterium O
, O
as O
an O
example O
. O

Selected O
surface O
proteins O
are O
introduced O
, O
their O
structure O
described O
, O
and O
, O
whenever O
available O
, O
their O
mechanisms O
of O
function O
on O
an O
atomic O
level O
are O
explained O
. O

Such O
mechanisms O
for O
hyaluronate O
lyase O
, O
pneumococcal O
surface O
protein O
A O
, O
pneumolysin O
, O
histidine O
- O
triad O
and O
fibronectin O
- O
binding O
proteins O
are O
discussed O
. O

Elucidation O
of O
molecular O
mechanisms O
of O
virulence O
factors O
is O
essential O
for O
the O
understanding O
of O
bacteria O
and O
their O
functional O
properties O
. O

Structural O
biology O
appears O
pivotal O
for O
these O
studies O
, O
as O
structural O
and O
mechanistic O
insights O
facilitate O
rational O
approach O
to O
the O
development O
of O
new O
treatments O
. O

Respiratory Habitat_B
carriage O
of O
Kingella Bacteria_B
kingae Bacteria_I
among O
healthy Habitat_B
children Habitat_I
. O

The O
role O
of O
Kingella Bacteria_B
kingae Bacteria_I
as O
an O
invasive O
pathogen O
of O
young Habitat_B
children Habitat_I
is O
being O
increasingly O
recognized O
, O
but O
the O
niche O
of O
the O
organism O
in O
the O
respiratory Habitat_B
tract Habitat_I
and O
its O
prevalence O
in O
the O
normal Habitat_B
flora Habitat_I
of Habitat_I
children Habitat_I
remain O
unknown O
. O

To O
investigate O
these O
two O
aspects O
throat Habitat_B
and O
nasopharyngeal Habitat_B
cultures O
were O
obtained O
every O
2 O
weeks O
from O
two O
cohorts Habitat_B
of Habitat_I
children Habitat_I
, Habitat_I
ages Habitat_I
6 Habitat_I
to Habitat_I
42 Habitat_I
months Habitat_I
on O
enrollment O
, O
attending O
a O
day Habitat_B
- Habitat_I
care Habitat_I
center Habitat_I
in O
southern O
Israel O
. O

To O
determine O
the O
age O
- O
related O
prevalence O
of O
K Bacteria_B
. Bacteria_I
kingae Bacteria_I
, O
throat Habitat_B
cultures O
were O
obtained O
from O
children Habitat_B
ages Habitat_I
6 Habitat_I
months Habitat_I
to Habitat_I
14 Habitat_I
years Habitat_I
hospitalized O
for O
elective O
surgery O
who O
had O
not O
received O
antibiotics O
during O
the O
previous O
30 O
days O
and O
from O
healthy Habitat_B
infants Habitat_I
younger Habitat_I
than Habitat_I
6 Habitat_I
months Habitat_I
attending O
a O
well Habitat_B
- Habitat_I
baby Habitat_I
- Habitat_I
care Habitat_I
clinic Habitat_I
for O
routine O
vaccinations O
. O

During O
an O
11 O
- O
month O
follow O
- O
up O
109 O
of O
624 O
( O
27 O
. O
5 O
% O
) O
throat Habitat_B
cultures Habitat_I
but O
none O
of O
the O
nasopharyngeal Habitat_B
cultures Habitat_I
obtained O
from O
48 O
day Habitat_B
- Habitat_I
care Habitat_I
center Habitat_I
attendees O
grew O
K Bacteria_B
. Bacteria_I
kingae Bacteria_I
. O

The O
monthly O
prevalence O
of O
K Bacteria_B
. Bacteria_I
kingae Bacteria_I
ranged O
from O
6 O
. O
1 O
to O
34 O
. O
6 O
% O
with O
December O
and O
April O
peaks O
. O

Overall O
35 O
of O
48 O
( O
72 O
. O
9 O
% O
) O
children Habitat_B
had O
at O
least O
one O
positive O
culture O
for O
the O
organism O
. O

Among O
the O
27 O
children Habitat_B
who O
had O
> O
or O
= O
2 O
positive O
cultures O
, O
continuous O
and O
intermittent O
patterns O
of O
carriage O
were O
observed O
. O

None O
of O
the O
colonized Habitat_B
children Habitat_I
experienced O
an O
invasive O
K Bacteria_B
. Bacteria_I
kingae Bacteria_I
infection O
. O

The O
prevalence O
of O
pharyngeal Habitat_B
carriage O
among O
surgical Habitat_B
patients Habitat_I
was O
8 O
. O
0 O
% O
, O
and O
the O
organism O
was O
not O
isolated O
from O
any O
of O
the O
infants Habitat_B
younger Habitat_I
than Habitat_I
6 Habitat_I
months Habitat_I
attending O
the O
well Habitat_B
- Habitat_I
baby Habitat_I
- Habitat_I
care Habitat_I
clinic Habitat_I
. O

Prevention O
and O
treatment O
of O
Staphylococcus Bacteria_B
biofilms Habitat_B
. O

Staphylococcus Bacteria_B
growth O
on O
medical Habitat_B
devices Habitat_I
represents O
a O
common O
occurrence O
that O
can O
lead O
to O
serious O
illness O
and O
death O
. O

Biomaterial Habitat_B
- O
associated O
infection O
, O
mostly O
caused O
by O
Staphylococcus Bacteria_B
epidermidis Bacteria_I
and O
Staphylococcus Bacteria_B
aureus Bacteria_I
, O
is O
fairly O
complicated O
by O
the O
organism O
' O
development O
of O
a O
biofilm Habitat_B
, O
which O
provides O
a O
microenvironment O
that O
protects O
from O
attack O
by O
the O
host Habitat_B
immune Habitat_I
system Habitat_I
and O
antibiotics O
. O

In O
this O
review O
we O
present O
recent O
insights O
regarding O
S Bacteria_B
. Bacteria_I
aureus Bacteria_I
and O
S Bacteria_B
. Bacteria_I
epidermidis Bacteria_I
structural O
and O
functional O
factors O
that O
are O
effective O
in O
biofilm Habitat_B
development O
and O
describe O
the O
regulation O
of O
their O
expression O
. O

On O
the O
basis O
of O
the O
knowledge O
gained O
, O
we O
also O
present O
the O
potential O
and O
limits O
of O
current O
biochemical O
and O
biophysical O
strategies O
aimed O
at O
preventing O
biofilm Habitat_B
formation O
or O
at O
the O
treatment O
of O
established Habitat_B
mature Habitat_I
biofilms Habitat_I
. O

Evaluation O
of O
a O
lytic O
bacteriophage O
, O
Φ O
st1 O
, O
for O
biocontrol O
of O
Salmonella Bacteria_B
enterica Bacteria_I
serovar Bacteria_I
Typhimurium Bacteria_I
in O
chickens Habitat_B
. O

In O
this O
study O
, O
a O
Salmonella Bacteria_B
Typhimurium Bacteria_I
lytic O
bacteriophage O
, O
Φ O
st1 O
, O
which O
was O
isolated O
from O
chicken Habitat_B
faecal O
material O
, O
was O
evaluated O
as O
a O
candidate O
for O
biocontrol O
of O
Salmonella Bacteria_B
in O
chickens Habitat_B
. O

The O
morphology O
of O
Φ O
st1 O
showed O
strong O
resemblance O
to O
members O
of O
the O
Siphoviridae O
family O
. O

Φ O
st1 O
was O
observed O
to O
be O
a O
DNA O
phage O
with O
an O
estimated O
genome O
size O
of O
121 O
kbp O
. O

It O
was O
found O
to O
be O
able O
to O
infect O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
and O
S Bacteria_B
. Bacteria_I
Hadar Bacteria_I
, O
with O
a O
stronger O
lytic O
activity O
against O
the O
former O
. O

Subsequent O
characterisation O
of O
Φ O
st1 O
against O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
showed O
that O
Φ O
st1 O
has O
a O
latent O
period O
of O
40 O
min O
with O
an O
average O
burst O
size O
of O
22 O
particles O
per O
infective O
centre O
. O

Approximately O
86 O
. O
1 O
% O
of O
the O
phage O
adsorbed O
to O
the O
host Habitat_B
cells Habitat_I
within O
the O
initial O
5 O
min O
of O
infection O
. O

At O
the O
optimum O
multiplicity O
of O
infection O
( O
MOI O
) O
( O
0 O
. O
1 O
) O
, O
the O
highest O
reduction O
rate O
of O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
( O
6 O
. O
6 O
log₁₀ O
CFU O
/ O
ml O
) O
and O
increment O
in O
phage O
titre O
( O
3 O
. O
8 O
log₁₀ O
PFU O
/ O
ml O
) O
was O
observed O
. O

Φ O
st1 O
produced O
adsorption O
rates O
of O
88 O
. O
4 O
- O
92 O
. O
2 O
% O
at O
pH7 O
- O
9 O
and O
demonstrated O
the O
highest O
bacteria O
reduction O
( O
6 O
. O
6 O
log₁₀ O
CFU O
/ O
ml O
) O
at O
pH9 O
. O

Φ O
st1 O
also O
showed O
an O
insignificant O
different O
( O
P O
> O
0 O
. O
05 O
) O
reduction O
rate O
of O
host Habitat_B
cells Habitat_I
at O
37 O
° O
C O
( O
6 O
. O
4 O
log₁₀ O
CFU O
/ O
ml O
) O
and O
42 O
° O
C O
( O
6 O
. O
0 O
log₁₀ O
CFU O
/ O
ml O
) O
. O

The O
in O
vivo O
study O
using O
Φ O
st1 O
showed O
that O
intracloacal Habitat_B
inoculation O
of O
~ O
10¹² O
PFU O
/ O
ml O
of O
the O
phage O
in O
the O
chickens Habitat_B
challenged O
with O
~ O
10¹⁰ O
CFU O
/ O
ml O
of O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
was O
able O
to O
reduce O
( O
P O
< O
0 O
. O
05 O
) O
the O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
more O
rapidly O
than O
the O
untreated O
group O
. O

The O
Salmonella Bacteria_B
count O
reduced O
to O
2 O
. O
9 O
log₁₀ O
CFU O
/ O
ml O
within O
6h O
of O
post O
- O
challenge O
and O
S Bacteria_B
. Bacteria_I
Typhimurium Bacteria_I
was O
not O
detected O
at O
and O
after O
24h O
of O
post O
- O
challenge O
. O

Reduction O
of O
Salmonella Bacteria_B
count O
in O
visceral Habitat_B
organs Habitat_I
was O
also O
observed O
at O
6h O
post O
- O
challenge O
. O

Approximately O
1 O
. O
6 O
log₁₀ O
FU O
/ O
ml O
Φ O
st1 O
was O
found O
to O
persist O
in O
the O
caecal Habitat_B
wall O
of O
the O
chicks Habitat_B
at O
72 O
h O
of O
post O
- O
challenge O
. O

The O
present O
study O
indicated O
that O
Φ O
st1 O
may O
serve O
as O
a O
potential O
biocontrol O
agent O
to O
reduce O
the O
Salmonella Bacteria_B
count O
in O
caecal Habitat_B
content Habitat_I
of Habitat_I
chickens Habitat_I
. O

Optimization O
of O
the O
production O
of O
Chondrus Habitat_B
crispus Habitat_I
hexose O
oxidase O
in O
Pichia Habitat_B
pastoris Habitat_I
. O

Hexose O
oxidase O
( O
D O
- O
hexose O
: O
O O
( O
2 O
) O
- O
oxidoreductase O
, O
EC O
1 O
. O
1 O
. O
3 O
. O
5 O
, O
HOX O
) O
normally O
found O
in O
the O
red Habitat_B
alga Habitat_I
Chondrus Habitat_I
crispus Habitat_I
was O
produced O
heterologously O
in O
different O
host O
systems O
. O

Full O
- O
length O
HOX O
polypeptide O
was O
produced O
in O
Escherichia Bacteria_B
coli Bacteria_I
, O
but O
no O
HOX O
activity O
could O
be O
detected O
. O

In O
contrast O
, O
active O
HOX O
could O
be O
produced O
in O
the O
methylotrophic Habitat_B
yeast Habitat_I
Pichia Habitat_I
pastoris Habitat_I
. O

Several O
growth O
physiological O
and O
genetic O
approaches O
for O
optimization O
of O
hexose O
oxidase O
production O
in O
P Habitat_B
. Habitat_I
pastoris Habitat_I
were O
investigated O
. O

Our O
results O
indicate O
that O
specific O
growth O
conditions O
are O
essential O
in O
order O
to O
produce O
active O
HOX O
with O
the O
correct O
conformation O
. O

Furthermore O
, O
HOX O
seems O
to O
be O
activated O
by O
proteolytic O
cleavage O
of O
the O
full O
- O
length O
polypeptide O
chain O
into O
two O
fragments O
, O
which O
remain O
physically O
associated O
. O

Attempts O
to O
direct O
HOX O
to O
the O
extracellular O
compartment O
using O
the O
widely O
used O
secretion O
signals O
from O
Saccharomyces Habitat_B
cerevisiae Habitat_I
invertase O
or O
alpha O
- O
mating O
factor O
failed O
. O

However O
, O
we O
show O
in O
this O
study O
that O
HOX O
is O
transported O
out O
of O
P Habitat_B
. Habitat_I
pastoris Habitat_I
via O
a O
hitherto O
unknown O
mechanism O
and O
that O
it O
is O
possible O
to O
enhance O
this O
secretion O
by O
mutagenesis O
from O
below O
the O
detection O
limit O
to O
at O
least O
250 O
mg O
extracellular O
enzyme O
per O
liter O
. O

A O
new O
purification O
method O
for O
overproduced O
proteins O
sensitive O
to O
endogenous O
proteases O
. O

Proteolysisis O
a O
major O
problem O
in O
purification O
of O
overproduced O
proteins O
for O
structural O
studies O
. O

We O
developed O
a O
new O
method O
to O
avoid O
proteolysis O
of O
the O
products O
even O
in O
cases O
where O
popular O
protease O
inhibitors O
do O
not O
work O
effectively O
. O

When O
we O
cloned O
FlgF O
, O
a O
flagellar O
rod O
protein O
, O
from O
Salmonella Bacteria_B
typhimurium Bacteria_I
and O
overproduced O
it O
in O
Escherichia Bacteria_B
coli Bacteria_I
, O
FlgF O
was O
highly O
susceptible O
to O
cleavage O
by O
endogenous O
proteases O
after O
cell O
disruption O
even O
in O
the O
presence O
of O
various O
protease O
inhibitors O
. O

However O
, O
FlgF O
was O
not O
digested O
when O
the O
cells O
were O
disrupted O
in O
the O
presence O
of O
urea O
, O
which O
allowed O
us O
to O
develop O
the O
following O
new O
purification O
procedure O
. O

After O
cell O
disruption O
in O
the O
presence O
of O
urea O
and O
removal O
of O
the O
cell O
debris O
, O
the O
supernatant O
was O
passed O
through O
tandem O
- O
connected O
cation O
- O
and O
anion O
- O
exchange O
columns O
. O

Proteases O
were O
trapped O
in O
the O
cation O
- O
exchange O
column O
, O
and O
protease O
- O
free O
FlgF O
was O
eluted O
from O
the O
disconnected O
anion O
- O
exchange O
column O
. O

This O
gave O
a O
stable O
full O
- O
length O
product O
suitable O
for O
crystallization O
trials O
. O

The O
key O
procedures O
are O
cell O
disruption O
in O
the O
presence O
of O
urea O
and O
linked O
ion O
- O
exchange O
chromatography O
to O
quickly O
remove O
proteases O
as O
well O
as O
urea O
. O

This O
fast O
and O
simple O
method O
can O
be O
applied O
to O
purification O
of O
other O
overproduced O
proteins O
that O
are O
very O
sensitive O
to O
proteolysis O
. O

Occurrence O
of O
extended O
- O
spectrum O
beta O
- O
lactamase O
- O
producing O
Salmonella Bacteria_B
enterica Bacteria_I
in O
northern O
Spain O
with O
evidence O
of O
CTX O
- O
M O
- O
9 O
clonal O
spread O
among O
animals Habitat_B
and O
humans Habitat_B
. O

Among O
the O
1233 O
Salmonella Bacteria_B
enterica Bacteria_I
isolates O
obtained O
in O
two O
Spanish Habitat_B
hospitals Habitat_I
, O
five O
isolates O
( O
0 O
. O
4 O
% O
) O
( O
serovars O
: O
Virchow Bacteria_B
, O
four O
; O
Livingstone Bacteria_B
, O
one O
) O
had O
the O
phenotype O
of O
an O
extended O
- O
spectrum O
beta O
- O
lactamase O
( O
ESBL O
) O
producer O
. O

The O
genetic O
characterization O
of O
the O
ESBL O
of O
S Bacteria_B
. Bacteria_I
enterica Bacteria_I
Livingstone Bacteria_I
revealed O
a O
bla O
( O
SHV O
- O
2 O
) O
gene O
. O

The O
bla O
( O
CTX O
- O
M O
- O
10 O
) O
gene O
in O
a O
phage O
- O
related O
genetic O
environment O
was O
found O
in O
one O
S Bacteria_B
. Bacteria_I
enterica Bacteria_I
Virchow Bacteria_I
isolate O
, O
and O
the O
bla O
( O
CTX O
- O
M O
- O
9 O
) O
gene O
within O
the O
In60 O
integron O
was O
found O
in O
the O
three O
remaining O
Virchow Bacteria_B
isolates O
. O

These O
three O
isolates O
presented O
indistinguishable O
or O
closely O
related O
pulsed O
- O
field O
gel O
electrophoresis O
patterns O
among O
themselves O
and O
also O
as O
compared O
with O
the O
two O
other O
bla O
( O
CTX O
- O
M O
- O
9 O
) O
- O
containing O
isolates O
previously O
obtained O
from O
animals Habitat_B
. O

ESBL O
production O
is O
an O
emerging O
mechanism O
of O
resistance O
in O
S Bacteria_B
. Bacteria_I
enterica Bacteria_I
in O
the O
two O
studied O
hospitals Habitat_B
. O

Effects O
of O
2 O
, O
2 O
' O
, O
5 O
, O
5 O
' O
- O
tetrachlorobiphenyl O
and O
biphenyl O
on O
cell O
membranes O
of O
Ralstonia Bacteria_B
eutropha Bacteria_I
H850 Bacteria_I
. O

The O
effects O
of O
2 O
, O
2 O
' O
, O
5 O
, O
5 O
' O
- O
tetrachlorobiphenyl O
( O
TeCB O
) O
, O
a O
PCB O
congener O
, O
and O
biphenyl O
on O
the O
cytoplasmic O
membranes O
of O
Ralstonia Bacteria_B
eutropha Bacteria_I
H850 Bacteria_I
were O
investigated O
by O
measuring O
fluorescence O
polarization O
using O
1 O
, O
6 O
- O
diphenyl O
- O
1 O
, O
3 O
, O
5 O
- O
hexatriene O
( O
DPH O
) O
as O
the O
probe O
, O
and O
determining O
the O
cellular O
fatty O
acid O
compositions O
. O

TeCB O
significantly O
affected O
the O
membrane O
of O
R Bacteria_B
. Bacteria_I
eutropha Bacteria_I
H850 Bacteria_I
cells O
grown O
on O
fructose O
by O
decreasing O
DPH O
fluorescence O
polarization O
. O

In O
contrast O
, O
the O
membrane O
of O
cells O
grown O
on O
biphenyl O
showed O
a O
considerably O
less O
significant O
effect O
of O
TeCB O
on O
membrane O
polarization O
than O
in O
fructose O
- O
grown O
cells O
. O

An O
increase O
in O
the O
ratio O
of O
total O
saturated O
to O
unsaturated O
fatty O
acids O
in O
cells O
grown O
on O
biphenyl O
suggested O
less O
of O
a O
fluidizing O
effect O
of O
TeCB O
on O
membranes O
in O
those O
cells O
. O

When O
biphenyl O
- O
grown O
cells O
were O
transferred O
back O
to O
a O
fructose Habitat_B
medium Habitat_I
, O
they O
required O
25 O
generations O
for O
the O
membrane O
polarization O
and O
fatty O
acid O
compositions O
of O
these O
cells O
to O
revert O
back O
to O
those O
of O
the O
initial O
fructose O
- O
grown O
cells O
. O

The O
re O
- O
adaptation O
to O
a O
change O
in O
temperature O
required O
only O
five O
generations O
to O
return O
to O
normal O
. O

These O
results O
show O
that O
biphenyl O
affects O
cells O
in O
more O
ways O
than O
simply O
fluidizing O
the O
cytoplasmic O
membrane O
. O

[ O
Experimental O
and O
clinical O
studies O
of O
flomoxef O
in O
the O
field O
of O
obstetrics O
and O
gynecology O
. O

Representative O
Committee O
Members O
of O
the O
Research O
Team O
for O
Infections O
in O
the O
Field O
of O
Obstetrics O
and O
Gynecology O
] O
. O

Flomoxef O
( O
FMOX O
) O
has O
a O
broad O
antibacterial O
spectrum O
against O
Gram O
- O
positive O
and O
Gram O
- O
negative O
bacteria O
; O
especially O
its O
potent O
antibacterial O
activity O
against O
Staphylococcus Bacteria_B
aureus Bacteria_I
is O
a O
significant O
advantage O
that O
may O
not O
be O
found O
with O
other O
cephem O
compounds O
. O

In O
our O
determination O
of O
its O
antibacterial O
potency O
against O
various O
clinical Habitat_B
isolates O
obtained O
from O
clinical Habitat_B
materials Habitat_I
( Habitat_I
amniotic Habitat_I
fluid Habitat_I
, Habitat_I
intrauterine Habitat_I
secretions Habitat_I
, Habitat_I
exudates Habitat_I
of Habitat_I
the Habitat_I
pelvic Habitat_I
dead Habitat_I
space Habitat_I
) Habitat_I
of Habitat_I
patients Habitat_I
with Habitat_I
various Habitat_I
infections Habitat_I
, O
we O
obtained O
results O
representing O
specific O
features O
of O
this O
drug O
. O

From O
the O
results O
, O
the O
drug O
may O
be O
expected O
to O
produce O
an O
excellent O
effect O
in O
the O
treatment O
of O
various O
infections O
. O

Our O
study O
on O
drug O
concentrations O
in O
body Habitat_B
fluids Habitat_I
and O
genital Habitat_B
tissues O
demonstrated O
a O
good O
transfer O
of O
this O
drug O
into O
various O
tissues O
; O
in O
every O
tissue O
examined O
, O
the O
drug O
administered O
by O
the O
usual O
method O
in O
the O
usual O
dose O
yielded O
a O
concentration O
exceeding O
MIC O
for O
principal O
pathogens O
, O
thus O
promising O
a O
good O
clinical O
response O
. O

Indeed O
a O
high O
clinical O
efficacy O
rate O
of O
90 O
. O
1 O
% O
( O
good O
to O
very O
good O
responses O
) O
was O
obtained O
in O
a O
clinical O
trial O
involving O
222 O
cases O
. O

Administration O
of O
the O
drug O
in O
2 O
g O
quantity O
daily O
produced O
a O
high O
response O
rate O
of O
92 O
. O
8 O
% O
. O

It O
was O
especially O
noteworthy O
that O
a O
good O
response O
was O
obtained O
in O
30 O
of O
32 O
cases O
( O
93 O
. O
8 O
% O
) O
in O
which O
other O
cephem O
compounds O
had O
failed O
. O

In O
evaluation O
of O
the O
bacteriological O
effect O
, O
furthermore O
, O
the O
drug O
showed O
an O
excellent O
rate O
of O
bacterial O
elimination O
. O

In O
conclusion O
, O
this O
drug O
is O
expected O
to O
be O
greatly O
useful O
in O
the O
light O
of O
its O
good O
transfer O
into O
genital Habitat_B
tissues Habitat_I
and O
its O
strong O
antibacterial O
activities O
against O
Gram O
- O
positive O
cocci O
, O
Gram O
- O
negative O
bacteria O
and O
anaerobes O
as O
well O
as O
against O
multiple O
bacterial O
infections O
predominating O
among O
women Habitat_B
with Habitat_I
genital Habitat_I
infections Habitat_I
. O

Campylobacter Bacteria_B
- O
- O
a O
tale O
of O
two O
protein O
glycosylation O
systems O
. O

Post O
- O
translational O
glycosylation O
is O
a O
universal O
modification O
of O
proteins O
in O
eukarya Habitat_B
, O
archaea O
and O
bacteria O
. O

Two O
recent O
publications O
describe O
the O
first O
confirmed O
report O
of O
a O
bacterial O
N O
- O
linked O
glycosylation O
pathway O
in O
the O
human Habitat_B
gastrointestinal O
pathogen O
Campylobacter Bacteria_B
jejuni Bacteria_I
. O

In O
addition O
, O
an O
O O
- O
linked O
glycosylation O
pathway O
has O
been O
identified O
and O
characterized O
in O
C Bacteria_B
. Bacteria_I
jejuni Bacteria_I
and O
the O
related O
species O
Campylobacter Bacteria_B
coli Bacteria_I
. O

Both O
pathways O
have O
similarity O
to O
the O
respective O
N O
- O
and O
O O
- O
linked O
glycosylation O
processes O
in O
eukaryotes Habitat_B
. O

In O
bacteria O
, O
homologues O
of O
the O
genes O
in O
both O
pathways O
are O
found O
in O
other O
organisms O
, O
the O
complex O
glycans O
linked O
to O
the O
glycoproteins O
share O
common O
biosynthetic O
precursors O
and O
these O
modifications O
could O
play O
similar O
biological O
roles O
. O

Thus O
, O
Campylobacter Bacteria_B
provides O
a O
unique O
model O
system O
for O
the O
elucidation O
and O
exploitation O
of O
glycoprotein O
biosynthesis O
. O

Surveillance O
for O
upper Habitat_B
respiratory Habitat_I
tract Habitat_I
disease O
and O
Mycoplasma Bacteria_B
in O
free Habitat_B
- Habitat_I
ranging Habitat_I
gopher Habitat_I
tortoises Habitat_I
( O
Gopherus Habitat_B
polyphemus Habitat_I
) O
in O
Georgia O
, O
USA O
. O

Abstract O
Upper Habitat_B
respiratory Habitat_I
tract Habitat_I
disease O
( O
URTD O
) O
in O
the O
gopher Habitat_B
tortoise Habitat_I
( O
Gopherus Habitat_B
polyphemus Habitat_I
) O
is O
highly O
contagious O
and O
has O
been O
implicated O
in O
the O
reduction O
of O
populations O
throughout O
the O
range O
. O

With O
the O
exception O
of O
a O
few O
limited O
studies O
, O
the O
prevalence O
of O
URTD O
in O
Georgia Habitat_B
, Habitat_I
USA Habitat_I
tortoise Habitat_I
populations Habitat_I
is O
poorly O
known O
. O

We O
found O
that O
exposure O
to O
Mycoplasma Bacteria_B
agassizii Bacteria_I
and O
Mycoplasma Bacteria_B
testudineum Bacteria_I
, O
associated O
with O
URTD O
, O
varied O
geographically O
among O
11 O
Georgia Habitat_B
tortoise Habitat_I
populations Habitat_I
. O

The O
prevalence O
of O
antibodies O
to O
M Bacteria_B
. Bacteria_I
agassizii Bacteria_I
in O
individual O
populations O
was O
either O
very O
low O
( O
0 O
- O
3 O
% O
, O
n O
= O
7 O
populations O
) O
or O
very O
high O
( O
96 O
- O
100 O
% O
, O
n O
= O
4 O
populations O
) O
, O
whereas O
there O
was O
variation O
in O
the O
prevalence O
of O
antibodies O
to O
M Bacteria_B
. Bacteria_I
testudineum Bacteria_I
among O
populations O
( O
20 O
- O
61 O
% O
, O
n O
= O
10 O
) O
with O
only O
one O
site O
being O
negative O
. O

Five O
sites O
had O
tortoises Habitat_B
with O
antibodies O
to O
both O
pathogens O
, O
and O
these O
were O
the O
only O
sites O
where O
we O
observed O
tortoises Habitat_B
with O
clinical O
signs O
consistent O
with O
URTD O
. O

We O
did O
not O
find O
tortoises Habitat_B
with O
clinical O
signs O
of O
URTD O
at O
sites O
with O
tortoises Habitat_B
with O
antibodies O
only O
to O
M Bacteria_B
. Bacteria_I
testudineum Bacteria_I
, O
which O
provides O
evidence O
that O
this O
organism O
may O
be O
of O
limited O
pathogenicity O
for O
gopher Habitat_B
tortoises Habitat_I
. O

Collectively O
, O
these O
data O
indicate O
that O
both O
M Bacteria_B
. Bacteria_I
agassizii Bacteria_I
and O
M Bacteria_B
. Bacteria_I
testudineum Bacteria_I
are O
present O
in O
Georgia Habitat_B
populations Habitat_I
of Habitat_I
gopher Habitat_I
tortoises Habitat_I
and O
that O
clinical O
disease O
is O
apparent O
in O
populations O
where O
both O
pathogens O
are O
present O
. O

Additional O
research O
is O
needed O
to O
better O
understand O
the O
role O
of O
these O
two O
pathogens O
, O
and O
other O
potential O
pathogens O
, O
in O
the O
overall O
health O
of O
tortoise Habitat_B
populations Habitat_I
, O
especially O
if O
future O
conservation O
efforts O
involve O
translocation O
of O
tortoises Habitat_B
. O

Antibacterial O
properties O
of O
dermaseptin O
S4 O
derivatives O
under O
extreme O
incubation O
conditions O
. O

Antibacterial O
properties O
of O
the O
frog Habitat_B
- O
derived O
peptide O
dermaseptin O
S4 O
and O
a O
series O
of O
synthetic O
derivatives O
against O
the O
food Habitat_B
pathogen O
Escherichia Bacteria_B
coli Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
were O
investigated O
under O
extreme O
incubation O
conditions O
. O

The O
28 O
- O
mer O
analog O
K4K20S4 O
( O
P28 O
) O
displayed O
an O
MIC O
of O
8 O
microM O
and O
rapid O
bactericidal O
kinetics O
under O
standard O
culture O
conditions O
. O

Potent O
bactericidal O
properties O
were O
maintained O
at O
high Habitat_B
salt Habitat_I
concentrations Habitat_I
, O
under O
acidic O
or O
basic O
conditions O
, O
and O
at O
extreme O
temperatures O
. O

The O
N O
- O
terminal O
14 O
- O
mer O
sequence O
( O
P14 O
) O
displayed O
higher O
potency O
( O
MIC O
, O
4 O
microM O
) O
but O
only O
within O
a O
narrow O
range O
of O
incubation O
conditions O
, O
pointing O
to O
the O
importance O
of O
the O
C O
- O
terminal O
domain O
of O
P28 O
. O

The O
potency O
range O
was O
reextended O
upon O
conjugation O
of O
aminododecanoic O
acid O
to O
P14 O
. O

The O
resulting O
lipopeptide O
was O
even O
more O
potent O
( O
MIC O
, O
2 O
microM O
) O
and O
affected O
bacterial O
viability O
under O
most O
of O
the O
conditions O
tested O
, O
including O
in O
commercial Habitat_B
apple Habitat_I
juice Habitat_I
. O

The O
mechanistic O
implications O
of O
peptides O
' O
hydrophobicity O
, O
charge O
, O
structure O
, O
and O
binding O
to O
an O
idealized O
membrane O
were O
probed O
and O
are O
discussed O
here O
. O

Collectively O
, O
the O
data O
indicate O
interest O
in O
simple O
peptide O
- O
based O
compounds O
for O
design O
of O
antimicrobials O
that O
affect O
pathogens O
under O
a O
variable O
range O
of O
incubation O
conditions O
. O

The O
etiologic O
and O
epidemiologic O
spectrum O
of O
bronchiolitis O
in O
pediatric Habitat_B
practice O
. O

To O
develop O
a O
broad O
understanding O
of O
the O
causes O
and O
patterns O
of O
occurrence O
of O
wheezing O
associated O
respiratory Habitat_B
infections O
, O
we O
analyzed O
data O
from O
an O
11 O
- O
year O
study O
of O
acute O
lower O
respiratory Habitat_B
illness O
in O
a O
pediatric Habitat_B
practice O
. O

Although O
half O
of O
the O
WARI O
occurred O
in O
children Habitat_B
less Habitat_I
than Habitat_I
2 Habitat_I
years Habitat_I
of Habitat_I
age Habitat_I
, O
wheezing O
continued O
to O
be O
observed O
in O
19 O
% O
of O
children Habitat_B
greater Habitat_I
than Habitat_I
9 Habitat_I
years Habitat_I
of Habitat_I
age Habitat_I
who Habitat_I
had Habitat_I
lower Habitat_I
respiratory Habitat_I
illness Habitat_I
. O

Males Habitat_B
experienced O
LRI O
1 O
. O
25 O
times O
more O
often O
than O
did O
females Habitat_B
; O
the O
relative O
risk O
of O
males Habitat_B
for O
WARI O
was O
1 O
. O
35 O
. O

A O
nonbacterial O
pathogen O
was O
recovered O
from O
21 O
% O
of O
patients Habitat_B
with Habitat_I
WARI Habitat_I
; O
respiratory Habitat_B
syncytial O
virus O
, O
parainfluenza O
virus O
types O
1 O
and O
3 O
, O
adenoviruses O
, O
and O
Mycoplasma Bacteria_B
pneumoniae Bacteria_I
accounted O
for O
81 O
% O
of O
the O
isolates O
. O

Patient Habitat_B
age O
influenced O
the O
pattern O
of O
recovery O
of O
these O
agents O
. O

The O
most O
common O
cause O
of O
WARI O
in O
children Habitat_B
under Habitat_I
5 Habitat_I
years Habitat_I
of Habitat_I
age Habitat_I
was O
RSV O
whereas O
Mycoplasma Bacteria_B
pneumoniae Bacteria_I
was O
the O
most O
frequent O
isolate O
from O
school Habitat_B
age Habitat_I
children Habitat_I
with Habitat_I
wheezing Habitat_I
illness Habitat_I
. O

The O
data O
expand O
our O
understanding O
of O
the O
causes O
of O
WARI O
and O
are O
useful O
to O
diagnosticians Habitat_B
and O
to O
researchers Habitat_B
interested O
in O
the O
control O
of O
lower O
respiratory Habitat_B
disease O
. O

The O
presence O
of O
professional Habitat_B
phagocytes Habitat_I
dictates O
the O
number O
of O
host Habitat_B
cells Habitat_I
targeted O
for O
Yop O
translocation O
during O
infection O
. O

Type O
III O
secretion O
systems O
deliver O
effector O
proteins O
from O
Gram O
- O
negative O
bacterial O
pathogens O
into O
host Habitat_B
cells Habitat_I
, O
where O
they O
disarm O
host O
defences O
, O
allowing O
the O
pathogens O
to O
establish O
infection O
. O

Although O
Yersinia Bacteria_B
pseudotuberculosis Bacteria_I
delivers O
its O
effector O
proteins O
, O
called O
Yops O
, O
into O
numerous O
cell Habitat_B
types Habitat_I
grown Habitat_I
in Habitat_I
culture Habitat_I
, O
we O
show O
that O
during O
infection O
Y Bacteria_B
. Bacteria_I
pseudotuberculosis Bacteria_I
selectively O
targets O
Yops O
to O
professional Habitat_B
phagocytes Habitat_I
in Habitat_I
Peyer Habitat_I
' Habitat_I
s Habitat_I
patches Habitat_I
, O
mesenteric Habitat_B
lymph Habitat_I
nodes Habitat_I
and O
spleen Habitat_B
, O
although O
it O
colocalizes O
with O
B O
and O
T Habitat_B
cells Habitat_I
as O
well O
as O
professional Habitat_B
phagocytes Habitat_I
. O

Strikingly O
, O
in O
the O
absence O
of O
neutrophils Habitat_B
, O
the O
number O
of O
cells Habitat_B
with Habitat_I
translocated Habitat_I
Yops Habitat_I
was O
significantly O
reduced O
although O
the O
bacterial O
loads O
were O
similar O
, O
indicating O
that O
Y Bacteria_B
. Bacteria_I
pseudotuberculosis Bacteria_I
did O
not O
arbitrarily O
deliver O
Yops O
to O
the O
available O
cells Habitat_B
. O

Using O
isolated Habitat_B
splenocytes Habitat_I
, O
selective O
binding O
and O
selective O
targeting O
to O
professional Habitat_B
phagocytes Habitat_I
when O
bacteria O
were O
limiting O
was O
also O
observed O
, O
indicating O
that O
tissue O
architecture O
was O
not O
required O
for O
the O
tropism O
for O
professional Habitat_B
phagocytes Habitat_I
. O

In O
isolated Habitat_B
splenocytes Habitat_I
, O
YadA O
and O
Invasin O
increased O
the O
number O
of O
all O
cells Habitat_B
types O
with O
translocated O
Yops O
, O
but O
professional Habitat_B
phagocytes Habitat_I
were O
still O
preferentially O
translocated O
with O
Yops O
in O
the O
absence O
of O
these O
adhesins O
. O

Together O
these O
results O
indicate O
that O
Y Bacteria_B
. Bacteria_I
pseudotuberculosis Bacteria_I
discriminates O
among O
cells Habitat_B
it O
encounters O
during O
infection O
and O
selectively O
delivers O
Yops O
to O
phagocytes Habitat_B
while O
refraining O
from O
translocation O
to O
other O
cell Habitat_B
types O
. O

Biochemistry O
of O
Coxiella Bacteria_B
burnetii Bacteria_I
: O
Embden O
- O
Meyerhof O
pathway O
. O

Purified Habitat_B
preparations Habitat_I
of Habitat_I
Coxiella Habitat_I
burnetii Habitat_I
were O
examined O
for O
enzymes O
of O
the O
glycolytic O
pathway O
. O

Glucose O
- O
phosphate O
isomerase O
, O
fructose O
- O
1 O
, O
6 O
- O
diphosphatase O
, O
aldolase O
, O
glyceraldehyde O
- O
3 O
- O
phosphate O
dehydrogenase O
, O
and O
pyruvate O
kinase O
were O
shown O
to O
be O
present O
in O
C Habitat_B
. Habitat_I
burnetii Habitat_I
extracts Habitat_I
. O

Heat O
- O
killed O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
purified O
with O
normal Habitat_B
yolk Habitat_I
sacs Habitat_I
demonstrated O
no O
activity O
after O
disruption O
. O

Aldolase O
was O
shown O
to O
be O
of O
the O
class O
II O
type O
by O
complete O
inhibition O
of O
activity O
in O
the O
presence O
of O
8 O
x O
10 O
( O
- O
3 O
) O
m O
ethylenediaminetetraacetic O
acid O
. O

The O
host O
enzyme O
activity O
( O
normal O
and O
infected Habitat_B
yolk Habitat_I
sacs Habitat_I
) O
was O
not O
affected O
by O
the O
same O
treatment O
. O

When O
cellulose O
acetate O
electrophoresis O
was O
performed O
on O
the O
extracts O
, O
aldolase O
from O
both O
normal O
and O
infected Habitat_B
yolk Habitat_I
sacs Habitat_I
exhibited O
five O
isozyme O
bands O
, O
whereas O
aldolase O
from O
the O
C Habitat_B
. Habitat_I
burnetii Habitat_I
extract Habitat_I
appeared O
as O
a O
single O
band O
. O

[ O
The O
infections O
from O
" O
Serratia Bacteria_B
" O
in O
the O
Hospital Habitat_B
S Habitat_I
. Habitat_I
Camillo Habitat_I
De Habitat_I
Lellis Habitat_I
of O
Roma O
( O
Italy O
) O
( O
author O
' O
s O
transl O
) O
] O
. O

The O
three O
- O
dimensional O
structures O
of O
two O
beta O
- O
agarases O
. O

Agars O
are O
important O
gelifying O
agents O
for O
biochemical O
use O
and O
the O
food O
industry O
. O

To O
cleave O
the O
beta O
- O
1 O
, O
4 O
- O
linkages O
between O
beta O
- O
d O
- O
galactose O
and O
alpha O
- O
l O
- O
3 O
, O
6 O
- O
anhydro O
- O
galactose O
residues O
in O
the O
red Habitat_B
algal Habitat_I
galactans O
known O
as O
agars O
, O
marine Habitat_B
bacteria O
produce O
polysaccharide O
hydrolases O
called O
beta O
- O
agarases O
. O

Beta O
- O
agarases O
A O
and O
B O
from O
Zobellia Bacteria_B
galactanivorans Bacteria_I
Dsij Bacteria_I
have O
recently O
been O
biochemically O
characterized O
. O

Here O
we O
report O
the O
first O
crystal O
structure O
of O
these O
two O
beta O
- O
agarases O
. O

The O
two O
proteins O
were O
overproduced O
in O
Escherichia Bacteria_B
coli Bacteria_I
and O
crystallized O
, O
and O
the O
crystal O
structures O
were O
determined O
at O
1 O
. O
48 O
and O
2 O
. O
3 O
A O
for O
beta O
- O
agarases O
A O
and O
B O
, O
respectively O
. O

The O
structure O
of O
beta O
- O
agarase O
A O
was O
solved O
by O
the O
multiple O
anomalous O
diffraction O
method O
, O
whereas O
beta O
- O
agarase O
B O
was O
solved O
with O
molecular O
replacement O
using O
beta O
- O
agarase O
A O
as O
model O
. O

Their O
structures O
adopt O
a O
jelly O
roll O
fold O
with O
a O
deep O
active O
site O
channel O
harboring O
the O
catalytic O
machinery O
, O
namely O
the O
nucleophilic O
residues O
Glu O
- O
147 O
and O
Glu O
- O
184 O
and O
the O
acid O
/ O
base O
residues O
Glu O
- O
152 O
and O
Glu O
- O
189 O
for O
beta O
- O
agarases O
A O
and O
B O
, O
respectively O
. O

The O
structures O
of O
the O
agarases O
were O
compared O
with O
those O
of O
two O
lichenases O
and O
of O
a O
kappa O
- O
carrageenase O
, O
which O
all O
belong O
to O
family O
16 O
of O
the O
glycoside O
hydrolases O
in O
order O
to O
pinpoint O
the O
residues O
responsible O
for O
their O
widely O
differing O
substrate O
specificity O
. O

The O
relationship O
between O
structure O
and O
enzymatic O
activity O
of O
the O
two O
beta O
- O
agarases O
from O
Z Bacteria_B
. Bacteria_I
galactanivorans Bacteria_I
Dsij Bacteria_I
was O
studied O
by O
analysis O
of O
the O
degradation O
products O
starting O
with O
different O
oligosaccharides O
. O

The O
combination O
of O
the O
structural O
and O
biochemical O
results O
allowed O
the O
determination O
of O
the O
number O
of O
subsites O
present O
in O
the O
catalytic O
cleft O
of O
the O
beta O
- O
agarases O
. O

A O
large O
outbreak O
of O
Salmonella Bacteria_B
Paratyphi Bacteria_I
A Bacteria_I
infection O
among O
israeli Habitat_B
travelers Habitat_I
to O
Nepal O
. O

In O
Asia O
, O
Salmonella Bacteria_B
Paratyphi Bacteria_I
A Bacteria_I
is O
an O
emerging O
infection O
, O
and O
travelers Habitat_B
are O
increasingly O
at O
risk O
. O

During O
October O
2009 O
- O
November O
2009 O
, O
an O
outbreak O
in O
S Bacteria_B
. Bacteria_I
Paratyphi Bacteria_I
A Bacteria_I
infection O
was O
noted O
in O
Israeli Habitat_B
travelers Habitat_I
returning O
from O
Nepal O
. O

An O
outbreak O
investigation O
included O
a O
standardized O
exposure O
questionnaire O
admitted O
to O
all O
patients Habitat_B
and O
medical O
chart O
abstraction O
. O

Isolates O
were O
tested O
for O
antimicrobial O
susceptibility O
and O
pulsed O
- O
field O
gel O
electrophoresis O
( O
PFGE O
) O
. O

During O
1 O
October O
2009 O
- O
30 O
November O
2009 O
, O
37 O
Israeli Habitat_B
travelers Habitat_I
returning O
from O
Nepal O
were O
diagnosed O
with O
S Bacteria_B
. Bacteria_I
Paratyphi Bacteria_I
A Bacteria_I
bacteremia O
. O

All O
37 O
case O
isolates O
had O
an O
identical O
pattern O
on O
PFGE O
, O
and O
all O
were O
nalidixic O
acid O
resistant O
. O

Only O
1 O
food Habitat_B
venue Habitat_I
was O
frequented O
by O
all O
the O
outbreak O
cases O
, O
with O
the O
largest O
number O
of O
exposures O
occurring O
around O
the O
Jewish O
New O
Year O
. O

All O
patients Habitat_B
recovered O
without O
complications O
. O

Time O
to O
defervescence O
in O
17 O
patients Habitat_B
treated Habitat_I
with Habitat_I
ceftriaxone Habitat_I
and Habitat_I
azithromycin Habitat_I
combination Habitat_I
was O
3 O
. O
2 O
days O
( O
± O
1 O
. O
7 O
) O
, O
whereas O
in O
13 O
cases Habitat_B
treated Habitat_I
with Habitat_I
ceftriaxone Habitat_I
monotherapy Habitat_I
, O
the O
time O
to O
defervescence O
was O
6 O
. O
6 O
days O
( O
± O
1 O
. O
8 O
; O
P O
< O
. O
001 O
) O
. O

A O
point O
- O
source O
, O
" O
Paratyphoid O
Mary O
" O
- O
like O
outbreak O
was O
identified O
among O
Israeli Habitat_B
travelers Habitat_I
to O
Nepal O
. O

Combination O
Ceftriaxone O
- O
Azithromycin O
therapy O
may O
provide O
a O
therapeutic O
advantage O
over O
monotherapy O
, O
and O
merits O
further O
clinical O
trials O
. O

A O
putative O
rolB O
gene O
homologue O
of O
the O
Agrobacterium Bacteria_B
rhizogenes Bacteria_I
TR O
- O
DNA O
has O
different O
morphogenetic O
activity O
in O
tobacco Habitat_B
than O
rolB O
. O

Agrobacterium Bacteria_B
rhizogenes Bacteria_I
strains O
of O
the O
agropine O
type O
harbor O
on O
their O
Ri O
- O
plasmid O
two O
T O
- O
DNAs O
, O
a O
left O
TL O
- O
DNA O
and O
a O
right O
TR O
- O
DNA O
. O

The O
rolB O
gene O
of O
the O
TL O
- O
DNA O
is O
the O
major O
factor O
in O
the O
pathogenesis O
of O
the O
hairy Habitat_B
- Habitat_I
root Habitat_I
disease O
and O
its O
constitutive O
expression O
interfere O
profoundly O
with O
plant Habitat_B
morphogenesis O
. O

We O
have O
tested O
whether O
the O
expression O
of O
its O
sequence O
related O
putative O
homologue O
from O
the O
TR O
- O
DNA O
( O
rolBTR O
) O
may O
cause O
also O
bacterial O
virulence O
or O
affect O
plant Habitat_B
development O
. O

Unlike O
rolB O
, O
rolBTR O
is O
unable O
to O
induce O
root Habitat_B
formation O
on O
tobacco Habitat_B
leaf Habitat_I
discs Habitat_I
. O

Tobacco Habitat_B
plants Habitat_I
expressing Habitat_I
a Habitat_I
chimeric Habitat_I
35S Habitat_I
: Habitat_I
: Habitat_I
rolBTR Habitat_I
gene Habitat_I
have O
reduced O
stature O
, O
off Habitat_B
- Habitat_I
shoots Habitat_I
at Habitat_I
the Habitat_I
stem Habitat_I
base Habitat_I
and O
bent O
and O
wrinkled Habitat_B
leaves Habitat_I
with Habitat_I
epinastic Habitat_I
growth Habitat_I
. O

14 O
N O
- O
terminal O
amino O
acids O
which O
are O
absent O
in O
the O
rolB O
protein O
are O
indispensable O
to O
rolBTR O
protein O
activity O
. O

The O
characteristic O
tyrosine O
phosphatase O
super O
family O
motif O
CX5R O
is O
absent O
in O
the O
rolBTR O
protein O
. O

For O
rolB O
this O
motif O
is O
possibly O
functionally O
relevant O
. O

We O
conclude O
that O
the O
rolBTR O
gene O
product O
has O
morphogenic O
activity O
but O
is O
not O
a O
functional O
homologue O
of O
the O
rolB O
protein O
. O

The O
effect O
of O
interferon O
- O
gamma O
and O
lipopolysaccharide O
on O
the O
growth O
of O
Francisella Bacteria_B
tularensis Bacteria_I
LVS Bacteria_I
in O
murine Habitat_B
macrophage O
- O
like O
cell O
line O
J774 O
. O

Francisella Bacteria_B
tularensis Bacteria_I
, O
a O
causative O
agent O
of O
human Habitat_B
tularemia O
, O
displaying O
the O
ability O
to O
proliferate O
inside O
the O
human Habitat_B
cells Habitat_I
. O

To O
evaluate O
the O
growth O
potential O
of O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
LVS Bacteria_I
strain O
in O
macrophage Habitat_B
- O
like O
cell O
line O
J774 O
modulated O
by O
recombinant O
interferon O
gamma O
and O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
derived O
lipopolysaccharide O
. O

Stimulation O
of O
J774 Habitat_B
cells Habitat_I
either O
by O
interferon O
- O
gamma O
or O
lipopolysaccharide O
alone O
, O
or O
especially O
in O
combination O
before O
infection O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
, O
revealed O
protective O
effects O
. O

Higher O
concentrations O
of O
stimulating O
agents O
were O
needed O
to O
inhibit O
ongoing O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
infection O
. O

Stimulation O
of O
J774 Habitat_B
cell Habitat_I
line Habitat_I
by O
combination O
of O
interferon O
- O
gamma O
with O
lipopolysaccharide O
inhibits O
the O
intracellular O
growth O
of O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
. O

An O
evaluation O
of O
selective Habitat_B
broths Habitat_I
based O
on O
the O
bi O
- O
selenite O
ion O
and O
on O
hypertonic O
strontium O
chloride O
in O
Salmonellae Bacteria_B
detection O
in O
egg Habitat_B
products O
. O

Of O
the O
104 O
isolations O
of O
Salmonella Bacteria_B
sp O
. O

from O
egg Habitat_B
pulp Habitat_I
, O
97 O
were O
obtained O
from O
strontium Habitat_B
chloride Habitat_I
M Habitat_I
broth Habitat_I
, O
42 O
from O
strontium Habitat_B
selenite Habitat_I
broth Habitat_I
and O
57 O
from O
strontium Habitat_B
selenite Habitat_I
A Habitat_I
broth Habitat_I
. O

The O
results O
suggest O
that O
the O
first O
medium O
may O
be O
used O
more O
successfully O
than O
bi Habitat_B
- Habitat_I
selenite Habitat_I
based Habitat_I
media Habitat_I
for O
enrichment O
and O
subsequent O
detection O
of O
salmonellae Bacteria_B
in O
egg Habitat_B
products Habitat_I
; O
however O
, O
the O
growth O
of O
S Bacteria_B
. Bacteria_I
pullorum Bacteria_I
was O
not O
satisfactory O
in O
strontium Habitat_B
chloride Habitat_I
M Habitat_I
broth Habitat_I
. O

High O
genetic O
diversity O
of O
nontypeable O
Haemophilus Bacteria_B
influenzae Bacteria_I
isolates O
from O
two O
children Habitat_B
attending Habitat_I
a Habitat_I
day Habitat_I
care Habitat_I
center Habitat_I
. O

Twenty O
- O
one O
nontypeable Bacteria_B
Haemophilus Bacteria_I
influenzae Bacteria_I
( Bacteria_I
NTHi Bacteria_I
) Bacteria_I
isolates O
from O
the O
throats Habitat_B
of Habitat_I
two Habitat_I
healthy Habitat_I
children Habitat_I
were O
genotyped O
by O
multilocus O
sequence O
typing O
. O

Nine O
unique O
sequence O
types O
( O
STs O
) O
were O
identified O
. O

These O
STs O
were O
scattered O
throughout O
the O
phylogenetic O
tree O
of O
reported O
NTHi Bacteria_B
STs O
, O
demonstrating O
the O
high O
level O
of O
NTHi Bacteria_B
diversity O
found O
in O
colonized Habitat_B
children Habitat_I
. O

Rapid O
detection O
with O
monoclonal O
antibodies O
of O
Chlamydia Bacteria_B
trachomatis Bacteria_I
in O
urethral Habitat_B
smears O
and O
urine Habitat_B
sediments O
. O

[ O
Changes O
of O
pathogens O
and O
susceptibility O
to O
antibiotics O
in O
hematology Habitat_B
ward Habitat_I
from O
years O
2001 O
to O
2005 O
] O
. O

The O
purpose O
of O
this O
study O
was O
to O
determine O
the O
changes O
of O
pathogens O
in O
hematological Habitat_B
ward Habitat_I
and O
susceptibility O
of O
patients Habitat_B
received Habitat_I
chemotherapy Habitat_I
to O
antibiotics O
. O

The O
pathogens O
were O
taken O
from O
blood O
, O
urine O
and O
sputum Habitat_B
of Habitat_I
patients Habitat_I
who Habitat_I
accepted Habitat_I
chemotherapy Habitat_I
from O
years O
2001 O
to O
2005 O
, O
then O
were O
isolated O
and O
identified O
. O

The O
susceptibility O
test O
was O
performed O
by O
disk O
diffusion O
method O
. O

The O
results O
showed O
that O
the O
total O
of O
418 O
strains O
were O
detected O
. O

Gram O
- O
negative O
bacteria O
were O
the O
most O
common O
of O
nosocomial Habitat_B
infection O
. O

Pseudomonas Bacteria_B
aeruginosa Bacteria_I
, O
Enterobacter Bacteria_B
cloacae Bacteria_I
, O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
account O
for O
the O
most O
of O
Gram O
negative O
- O
bacteria O
infection O
and O
most O
resistant O
to O
broad O
- O
spectrum O
penicillin O
, O
Acinetobacter Bacteria_B
baumannii Bacteria_I
showed O
a O
trend O
of O
increase O
. O

The O
ratios O
of O
gram O
positive O
bacteria O
and O
fungi Habitat_B
were O
increased O
slowly O
, O
mainly O
as O
Enterococcus Bacteria_B
and O
Candida Habitat_B
. O

Enterococcus Bacteria_B
is O
the O
most O
common O
cause O
of O
Gram O
- O
positive O
bacterial O
infection O
. O

Vancomycin O
resistance O
did O
not O
occur O
. O

It O
is O
concluded O
that O
Gram O
- O
negative O
bacteria O
are O
main O
cause O
of O
nosocomial Habitat_B
infection O
in O
patients Habitat_B
with Habitat_I
hematological Habitat_I
malignancies Habitat_I
. O

Gram O
positive O
bacteria O
and O
fungi Habitat_B
had O
been O
more O
frequent O
. O

Strains O
resistant O
to O
antimicrobial O
agents O
increase O
. O

Methylocella Bacteria_B
: O
a O
gourmand O
among O
methanotrophs O
. O

A O
recent O
article O
in O
Nature O
describes O
the O
ability O
of O
Methylocella Bacteria_B
silvestris Bacteria_I
to O
grow O
simultaneously O
on O
methane O
and O
longer O
chain O
alkanes O
, O
something O
never O
before O
observed O
in O
the O
microbial O
world O
. O

It O
adds O
to O
a O
growing O
list O
of O
unique O
metabolic O
traits O
that O
distinguish O
Methylocella Bacteria_B
from O
any O
other O
bacterium O
. O

Molecular O
cloning O
and O
expression O
of O
MyD88 O
in O
large Habitat_B
yellow Habitat_I
croaker Habitat_I
, O
Pseudosciaena Habitat_B
crocea Habitat_I
. O

Myeloid O
differentiation O
factor O
88 O
( O
MyD88 O
) O
is O
an O
adaptor O
protein O
involved O
in O
the O
interleukin O
- O
1 O
receptor O
and O
Toll O
- O
like O
receptor O
- O
induced O
activation O
of O
nuclear O
factor O
- O
kappaB O
( O
NF O
- O
kappaB O
) O
. O

In O
this O
report O
, O
the O
full O
- O
length O
cDNA O
of O
MyD88 O
was O
cloned O
from O
the O
large Habitat_B
yellow Habitat_I
croaker Habitat_I
, O
Pseudosciaena Habitat_B
crocea Habitat_I
. O

It O
was O
of O
1574 O
bp O
, O
including O
a O
5 O
' O
- O
terminal O
untranslated O
region O
( O
UTR O
) O
of O
89 O
bp O
, O
a O
3 O
' O
- O
terminal O
UTR O
of O
621bp O
and O
an O
open O
reading O
frame O
( O
ORF O
) O
of O
864 O
bp O
encoding O
a O
polypeptide O
of O
287 O
amino O
acids O
. O

It O
contained O
a O
typical O
death O
domain O
at O
the O
N O
- O
terminal O
and O
a O
conservative O
Toll O
/ O
IL O
- O
1R O
( O
TIR O
) O
domain O
structure O
at O
the O
C O
- O
terminal O
. O

The O
quantitative O
real O
- O
time O
reverse O
transcription O
PCR O
analysis O
revealed O
a O
broad O
expression O
of O
MyD88 O
with O
the O
highest O
expression O
in O
the O
spleen Habitat_B
and O
the O
weakest O
expression O
in O
the O
muscle Habitat_B
. O

The O
expression O
of O
MyD88 O
after O
challenge O
with O
formalin O
- O
inactivated O
Gram O
- O
negative O
bacterium O
Vibrio Bacteria_B
parahaemolyticus Bacteria_I
was O
tested O
in O
blood Habitat_B
, O
spleen Habitat_B
and O
liver Habitat_B
. O

It O
suggested O
that O
the O
highest O
expression O
was O
in O
the O
spleen Habitat_B
( O
p O
< O
0 O
. O
05 O
) O
with O
1 O
. O
9 O
times O
( O
at O
48 O
h O
) O
as O
much O
as O
that O
in O
the O
control O
and O
the O
lowest O
expression O
of O
MyD88 O
was O
in O
the O
liver Habitat_B
( O
p O
< O
0 O
. O
05 O
) O
with O
0 O
. O
29 O
times O
( O
at O
3h O
) O
of O
that O
in O
the O
control O
. O

These O
results O
indicated O
that O
as O
a O
universal O
key O
adaptor O
in O
the O
Toll O
- O
like O
receptor O
pathway O
in O
mammals Habitat_B
, O
MyD88 O
might O
play O
an O
important O
role O
in O
large Habitat_B
yellow Habitat_I
croaker Habitat_I
defense O
against O
pathogenic O
infection O
. O

An O
extensive O
repertoire O
of O
type O
III O
secretion O
effectors O
in O
Escherichia Bacteria_B
coli Bacteria_I
O157 Bacteria_I
and O
the O
role O
of O
lambdoid O
phages O
in O
their O
dissemination O
. O

Several O
pathogenic O
strains O
of O
Escherichia Bacteria_B
coli Bacteria_I
exploit O
type O
III O
secretion O
to O
inject O
" O
effector O
proteins O
" O
into O
human Habitat_B
cells Habitat_I
, O
which O
then O
subvert O
eukaryotic Habitat_B
cell Habitat_I
biology O
to O
the O
bacterium O
' O
s O
advantage O
. O

We O
have O
exploited O
bioinformatics O
and O
experimental O
approaches O
to O
establish O
that O
the O
effector O
repertoire O
in O
the O
Sakai Bacteria_B
strain O
of O
enterohemorrhagic O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
( Bacteria_I
EHEC Bacteria_I
) Bacteria_I
O157 Bacteria_I
: Bacteria_I
H7 Bacteria_I
is O
much O
larger O
than O
previously O
thought O
. O

Homology O
searches O
led O
to O
the O
identification O
of O
> O
60 O
putative O
effector O
genes O
. O

Thirteen O
of O
these O
were O
judged O
to O
be O
likely O
pseudogenes O
, O
whereas O
49 O
were O
judged O
to O
be O
potentially O
functional O
. O

In O
total O
, O
39 O
proteins O
were O
confirmed O
experimentally O
as O
effectors O
: O
31 O
through O
proteomics O
and O
28 O
through O
translocation O
assays O
. O

At O
the O
protein O
level O
, O
the O
EHEC Bacteria_B
effector O
sequences O
fall O
into O
> O
20 O
families O
. O

The O
largest O
family O
, O
the O
NleG O
family O
, O
contains O
14 O
members O
in O
the O
Sakai Bacteria_B
strain O
alone O
. O

EHEC Bacteria_B
also O
harbors O
functional O
homologs O
of O
effectors O
from O
plant Habitat_B
pathogens O
( O
HopPtoH O
, O
HopW O
, O
AvrA O
) O
and O
from O
Shigella Bacteria_B
( O
OspD O
, O
OspE O
, O
OspG O
) O
, O
and O
two O
additional O
members O
of O
the O
Map O
/ O
IpgB O
family O
. O

Genes O
encoding O
proven O
or O
predicted O
effectors O
occur O
in O
> O
20 O
exchangeable O
effector O
loci O
scattered O
throughout O
the O
chromosome O
. O

Crucially O
, O
the O
majority O
of O
functional O
effector O
genes O
are O
encoded O
by O
nine O
exchangeable O
effector O
loci O
that O
lie O
within O
lambdoid O
prophages O
. O

Thus O
, O
type O
III O
secretion O
in O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
is O
linked O
to O
a O
vast O
phage O
" O
metagenome O
, O
" O
acting O
as O
a O
crucible O
for O
the O
evolution O
of O
pathogenicity O
. O

Interactions O
of O
alkaline O
phosphatase O
and O
the O
cell O
wall O
of O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
. O

Spheroplasts O
prepared O
by O
lysozyme O
treatment O
of O
cells O
of O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
, O
suspended O
in O
20 O
% O
sucrose O
or O
0 O
. O
2 O
m O
MgCl O
( O
2 O
) O
, O
were O
examined O
in O
detail O
. O

Preparation O
of O
spheroplasts O
in O
the O
presence O
of O
0 O
. O
2 O
m O
Mg O
( O
2 O
+ O
) O
released O
periplasmic O
alkaline O
phosphatase O
, O
whereas O
preparation O
in O
the O
presence O
of O
20 O
% O
sucrose O
did O
not O
, O
even O
though O
untreated O
cells O
released O
phosphatase O
when O
suspended O
in O
sucrose O
in O
the O
absence O
of O
lysozyme O
. O

Biochemical O
characterizations O
of O
the O
sucrose Habitat_B
- Habitat_I
lysozyme Habitat_I
preparations Habitat_I
indicated O
that O
lysozyme O
mediated O
a O
reassociation O
of O
the O
released O
phosphatase O
with O
the O
spheroplasts O
. O

In O
addition O
, O
the O
enzyme O
released O
from O
whole O
cells O
suspended O
in O
20 O
% O
sucrose O
( O
which O
represents O
20 O
to O
40 O
% O
of O
the O
cell O
- O
bound O
phosphatase O
) O
reassociates O
with O
the O
cells O
in O
the O
presence O
of O
lysozyme O
. O

Electron O
microscopic O
examinations O
of O
various O
preparations O
revealed O
that O
phosphatase O
released O
in O
sucrose O
reassociated O
with O
the O
external O
cell O
wall O
layers O
in O
the O
presence O
of O
lysozyme O
, O
that O
sucrose O
- O
lysozyme O
prepared O
spheroplasts O
did O
not O
dissociate O
phosphatase O
which O
remained O
in O
the O
periplasm O
of O
sucrose O
- O
washed O
cells O
, O
and O
that O
phosphatase O
was O
never O
observed O
to O
be O
associated O
with O
the O
cytoplasmic O
membrane O
. O

A O
model O
to O
account O
for O
the O
binding O
of O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
alkaline O
phosphatase O
to O
the O
internal O
portion O
of O
the O
tripartite O
layer O
of O
the O
cell O
wall O
rather O
than O
to O
the O
cytoplasmic O
membrane O
or O
peptidoglycan O
layer O
is O
presented O
. O

Order O
of O
fusions O
between O
bacterial O
and O
mammalian Habitat_B
proteins O
can O
determine O
solubility O
in O
Escherichia Bacteria_B
coli Bacteria_I
. O

We O
made O
fusions O
between O
Escherichia Bacteria_B
coli Bacteria_I
maltose O
- O
binding O
protein O
( O
MBP O
) O
and O
the O
mammalian Habitat_B
aspartic O
proteinases O
pepsinogen O
or O
procathepsin O
D O
. O
When O
MBP O
was O
at O
the O
N O
- O
terminus O
, O
the O
fusions O
were O
soluble O
in O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
. O

When O
the O
order O
was O
reversed O
, O
the O
chimeric O
proteins O
formed O
inclusion O
bodies O
. O

The O
data O
suggest O
that O
the O
solubility O
of O
fusion O
proteins O
is O
controlled O
by O
whether O
the O
protein O
domains O
emerging O
first O
from O
the O
ribosome O
normally O
fold O
into O
soluble O
or O
insoluble O
states O
. O

The O
soluble O
MBP O
- O
aspartic O
proteinase O
fusions O
were O
stable O
but O
proteolytically O
inactive O
. O

MBP O
- O
pepsinogen O
, O
however O
, O
was O
efficiently O
renatured O
from O
8 O
M O
urea O
in O
vitro O
, O
suggesting O
that O
the O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
cytoplasm O
does O
not O
support O
folding O
of O
the O
mammalian Habitat_B
partner O
protein O
to O
the O
native O
state O
. O

Thus O
, O
inclusion O
body O
formation O
may O
be O
the O
consequence O
, O
rather O
than O
the O
cause O
, O
of O
non O
- O
native O
folding O
in O
vivo O
, O
and O
in O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
soluble O
proteins O
may O
fold O
into O
states O
different O
from O
those O
reached O
in O
vitro O
. O

Gamma Habitat_B
/ Habitat_I
delta Habitat_I
T Habitat_I
lymphocytes Habitat_I
in O
the O
BCG Habitat_B
granulomatous Habitat_I
lesions Habitat_I
. O

Recent O
studies O
in O
man O
and O
animal Habitat_B
models Habitat_I
have O
demonstrated O
that O
TCR Habitat_B
- Habitat_I
gamma Habitat_I
delta Habitat_I
- Habitat_I
bearing Habitat_I
T Habitat_I
cells Habitat_I
( O
gamma Habitat_B
delta Habitat_I
T Habitat_I
cells Habitat_I
) O
are O
activated O
by O
mycobacteria Bacteria_B
and O
accumulate O
in O
the O
sites O
of O
mycobacterial Bacteria_B
infection O
. O

Although O
the O
function O
of O
gamma Habitat_B
delta Habitat_I
T Habitat_I
cells Habitat_I
remains O
unclear O
, O
some O
data O
suggest O
a O
potential O
role O
for O
these O
cells Habitat_B
in O
the O
granulomatous Habitat_B
immune O
response O
. O

To O
address O
the O
presence O
of O
gamma Habitat_B
delta Habitat_I
T Habitat_I
cells Habitat_I
within O
the O
BCG Habitat_B
granulomas Habitat_I
, O
we O
have O
characterized O
the O
TCR O
phenotype O
of O
T Habitat_B
- Habitat_I
lymphocytes Habitat_I
present O
in O
the O
BCG Habitat_B
granulomatous Habitat_I
lesion Habitat_I
immunohistochemically O
using O
a O
monoclonal O
antibody O
to O
TCR O
delta O
1 O
and O
others O
. O

Fairly O
large O
numbers O
of O
gamma Habitat_B
delta Habitat_I
T Habitat_I
cells Habitat_I
were O
located O
at O
the O
periphery O
of O
the O
BCG Habitat_B
granulomas Habitat_I
without Habitat_I
necrosis Habitat_I
and O
most O
of O
them O
also O
expressed O
CD8 O
. O

However O
, O
gamma Habitat_B
delta Habitat_I
T Habitat_I
cells Habitat_I
were O
rarely O
present O
in O
the O
granulomas Habitat_B
with Habitat_I
central Habitat_I
caseous Habitat_I
necrosis Habitat_I
, Habitat_I
calcification Habitat_I
and Habitat_I
fibrotic Habitat_I
changes Habitat_I
. O

With O
these O
results O
, O
it O
might O
be O
speculated O
that O
the O
CD8 Habitat_B
+ Habitat_I
gamma Habitat_I
delta Habitat_I
T Habitat_I
lymphocytes Habitat_I
participate O
in O
the O
BCG Habitat_B
granuloma Habitat_I
formation O
mainly O
in O
the O
early O
stage O
. O

Arhodomonas Bacteria_B
aquaeolei Bacteria_I
gen O
. O
nov O
. O
, O
sp O
. O

nov O
. O
, O
an O
aerobic O
, O
halophilic O
bacterium O
isolated O
from O
a O
subterranean Habitat_B
brine Habitat_I
. O

Arhodomonas Bacteria_B
aquaeolei Bacteria_I
gen O
. O
nov O
. O
, O
sp O
. O

nov O
. O
, O
isolated O
from O
a O
petroleum Habitat_B
reservoir Habitat_I
production Habitat_I
fluid Habitat_I
, O
is O
described O
. O

The O
single O
isolate O
was O
an O
obligately O
halophilic O
, O
aerobic O
, O
gram O
- O
negative O
, O
oval O
rod O
- O
shaped O
bacterium O
that O
was O
actively O
motile O
by O
means O
of O
a O
single O
polar O
flagellum O
. O

It O
was O
catalase O
and O
oxidase O
positive O
. O

The O
isolate O
had O
a O
specific O
requirement O
for O
NaCl O
; O
growth O
occurred O
at O
NaCl O
concentrations O
between O
6 O
and O
20 O
% O
, O
and O
optimal O
growth O
occurred O
in O
the O
presence O
of O
15 O
% O
NaCl O
. O

This O
species O
metabolized O
primarily O
organic O
acids O
and O
required O
biotin O
for O
growth O
. O

The O
name O
Arhodomonas Bacteria_B
is O
proposed O
for O
the O
new O
genus O
, O
which O
was O
placed O
in O
the O
gamma O
subclass O
of O
the O
Proteobacteria Bacteria_B
on O
the O
basis O
of O
the O
results O
of O
a O
16S O
rRNA O
sequence O
analysis O
. O

Although O
A Bacteria_B
. Bacteria_I
aquaeolei Bacteria_I
is O
most O
closely O
related O
to O
purple Bacteria_B
sulfur Bacteria_I
bacteria Bacteria_I
( O
the O
genera O
Ectothiorhodospira Bacteria_B
and O
Chromatium Bacteria_B
) O
, O
it O
is O
not O
a O
phototrophic Habitat_B
microorganism Habitat_I
, O
which O
is O
consistent O
with O
its O
isolation O
from O
a O
subterranean Habitat_B
environment Habitat_I
. O

The O
major O
components O
of O
its O
cellular O
fatty O
acids O
were O
C16 O
: O
0 O
, O
C18 O
: O
1 O
, O
C19 O
: O
0 O
, O
C16 O
: O
1 O
, O
and O
C18 O
: O
0 O
acids O
. O

The O
DNA O
base O
composition O
of O
the O
type O
strain O
is O
67 O
mol O
% O
G O
+ O
C O
. O

The O
type O
and O
only O
strain O
is O
strain Bacteria_B
HA Bacteria_I
- Bacteria_I
1 Bacteria_I
( O
= O
ATCC Bacteria_B
49307 Bacteria_I
) O
. O

Real O
- O
time O
monitoring O
of O
hydrogen O
cyanide O
( O
HCN O
) O
and O
ammonia O
( O
NH₃ O
) O
emitted O
by O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
. O

We O
present O
the O
real O
- O
time O
monitoring O
of O
hydrogen O
cyanide O
( O
HCN O
) O
production O
from O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
( O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
) O
strains O
in O
vitro O
, O
using O
laser O
- O
based O
photoacoustic O
spectroscopy O
. O

Simultaneously O
, O
the O
production O
of O
ammonia O
( O
NH3 O
) O
was O
measured O
, O
and O
the O
influence O
of O
different O
factors O
( O
e O
. O
g O
. O

the O
medium O
, O
temperature O
and O
antibiotics O
treatment O
) O
was O
assessed O
. O

Both O
reference O
strains O
and O
clinical Habitat_B
isolates O
of O
patients Habitat_B
with Habitat_I
CF Habitat_I
were O
studied O
, O
and O
compared O
to O
other O
pathogens O
commonly O
present O
in O
lungs O
/ O
airways Habitat_B
of Habitat_I
CF Habitat_I
patients Habitat_I
. O

Hydrogen O
cyanide O
production O
starts O
to O
rise O
as O
soon O
as O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
bacteria O
reach O
the O
stationary O
phase O
( O
( O
9 O
. O
0 O
- O
9 O
. O
5 O
) O
× O
10 O
( O
9 O
) O
colony O
forming O
units O
, O
CFUs O
) O
, O
up O
to O
concentrations O
of O
14 O
. O
5 O
microliters O
per O
hour O
( O
µl O
  O
h O
( O
- O
1 O
) O
) O
. O

Different O
strains O
of O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
produced O
HCN O
to O
varying O
degrees O
, O
and O
addition O
of O
tobramycin O
strongly O
reduced O
HCN O
production O
within O
2 O
  O
h O
from O
application O
. O

Burkholderia Bacteria_B
cepacia Bacteria_I
also O
produced O
HCN O
( O
up O
to O
0 O
. O
35µl O
  O
h O
( O
- O
1 O
) O
in O
9 O
. O
0 O
  O
× O
  O
10 O
( O
9 O
) O
  O
CFU O
) O
while O
other O
pathogens O
( O
Aspergillus O
fumigatus O
, O
Stenotrophomonas Bacteria_B
maltophilia Bacteria_I
, O
Mycobacterium Bacteria_B
abscessus Bacteria_I
) O
did O
not O
produce O
detectable O
levels O
. O

Our O
study O
reveals O
for O
the O
first O
time O
a O
broad O
overview O
of O
the O
dynamics O
of O
the O
HCN O
production O
in O
vitro O
. O

[ O
The O
effect O
of O
omeprazole O
on O
healing O
of O
duodenal Habitat_B
ulcers Habitat_I
, O
Helicobacter Bacteria_B
pylori Bacteria_I
and O
gastritis O
] O
. O

Losec O
( O
omeprazole O
) O
Astra O
Co O
. O
is O
a O
blocker O
of O
the O
proton O
pump O
of O
the O
parietal Habitat_B
cell Habitat_I
. O

It O
inhibits O
basal O
and O
stimulated O
HCl Habitat_B
secretion Habitat_I
. O

It O
is O
used O
for O
treatment O
of O
gastroduodenal Habitat_B
ulcers Habitat_I
, O
reflux O
oesophagitis O
and O
Zollinger O
Ellison O
' O
s O
syndrome O
. O

In O
a O
group O
of O
17 O
patients Habitat_B
with Habitat_I
duodenal Habitat_I
ulcers Habitat_I
the O
authors O
investigated O
the O
effect O
of O
omeprazole O
on O
( O
1 O
) O
healing O
of O
duodenal Habitat_B
ulcers Habitat_I
and O
bulbitis O
after O
2 O
- O
4 O
weeks O
of O
therapy O
, O
( O
2 O
) O
elimination O
of O
Helicobacter Bacteria_B
pylori Bacteria_I
in O
the O
antrum Habitat_B
, O
( O
3 O
) O
chronic O
antral Habitat_B
gastritis O
. O

Ad O
1 O
. O

After O
two O
weeks O
of O
treatment O
the O
authors O
found O
that O
5 O
of O
17 O
chronic Habitat_B
duodenal Habitat_I
ulcers Habitat_I
were O
healed O
in O
the O
remainder O
substantial O
regression O
was O
found O
. O

Four O
- O
week O
treatment O
led O
to O
healing O
of O
16 O
from O
a O
total O
of O
17 O
ulcers Habitat_B
( O
P O
< O
0 O
. O
001 O
) O
, O
i O
. O
e O
. O
94 O
% O
. O

In O
subjects Habitat_B
with Habitat_I
ulcers Habitat_I
and Habitat_I
bulbitis Habitat_I
( O
12 O
patients Habitat_B
) O
the O
ulcer Habitat_B
healed O
in O
11 O
instances O
, O
in O
7 O
patients Habitat_B
residual O
bulbitis O
persisted O
. O

Ad O
2 O
. O

H Bacteria_B
. Bacteria_I
pylori Bacteria_I
was O
detected O
before O
treatment O
in O
16 O
of O
17 O
patients Habitat_B
, O
after O
treatment O
only O
in O
5 O
( O
P O
< O
0 O
. O
001 O
) O
. O

Ad O
3 O
. O

Chronic O
gastritis O
was O
recorded O
before O
treatment O
in O
all O
patients Habitat_B
. O

Treatment O
reduced O
its O
activity O
and O
the O
presence O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
. O

The O
in O
vitro O
assay O
of O
tuberculin O
hypersensitivity O
in O
Macaca Habitat_B
mulatta Habitat_I
sensitized Habitat_I
with Habitat_I
bacille Habitat_I
Calmette Habitat_I
Guerin Habitat_I
cell Habitat_I
wall Habitat_I
vaccine Habitat_I
and O
- O
or O
infected O
with O
virulent O
Mycobacterium Bacteria_B
tuberculosis Bacteria_I
. O

Ability O
of O
Lactobacillus Bacteria_B
gasseri Bacteria_I
K Bacteria_I
7 Bacteria_I
to O
inhibit O
Escherichia Bacteria_B
coli Bacteria_I
adhesion O
in O
vitro O
on O
Caco Habitat_B
- Habitat_I
2 Habitat_I
cells Habitat_I
and O
ex O
vivo O
on O
pigs Habitat_B
' O
jejunal Habitat_B
tissue O
. O

The O
ability O
of O
Lactobacillus Bacteria_B
( Bacteria_I
Lb Bacteria_I
. Bacteria_I
 Bacteria_I
) Bacteria_I
gasseri Bacteria_I
K Bacteria_I
7 O
to O
inhibit O
adhesion O
of O
Escherichia O
coli O
O8 O
: O
K88 O
to O
intestinal O
mucosa O
was O
studied O
on O
cultured O
Caco O
- O
2 O
cells O
and O
ex O
vivo O
on O
pigs O
' O
small O
intestinal O
tissue O
. O

Lactobacilli O
were O
added O
simultaneously O
with O
E O
. O
coli O
, O
before O
E O
. O
coli O
and O
after O
E O
. O
coli O
for O
competition O
, O
exclusion O
and O
displacement O
assays O
. O

The O
concentration O
of O
lactobacilli O
on O
fully O
differentiated O
Caco O
- O
2 O
cells O
was O
4 O
. O
5 O
+ O
/ O
- O
0 O
. O
3 O
x O
10 O
( O
8 O
) O
cfu O
/ O
well O
, O
while O
the O
concentration O
of O
E O
. O
coli O
varied O
from O
1 O
. O
5 O
x O
10 O
( O
6 O
) O
to O
4 O
. O
3 O
x O
10 O
( O
8 O
) O
cfu O
/ O
well O
. O

The O
number O
of O
E O
. O
coli O
adhered O
to O
Caco O
- O
2 O
monolayer O
( O
cfu O
/ O
well O
) O
was O
lineary O
correlated O
( O
R O
( O
2 O
) O
= O
0 O
. O
97 O
) O
to O
the O
concentration O
of O
added O
cells O
. O

In O
the O
assay O
simulating O
exclusion O
, O
E O
. O
coli O
adhesion O
was O
reduced O
by O
Lb O
. O

gasseri O
K O
7 O
strain O
by O
0 O
. O
1 O
to O
0 O
. O
6 O
log O
cfu O
/ O
well O
. O

The O
binding O
of O
E O
. O
coli O
was O
inhibited O
even O
more O
when O
incubated O
simultaneously O
with O
lactobacilli O
, O
particularly O
at O
the O
lowest O
concentration O
of O
E O
. O
coli O
( O
ratio O
E O
. O
coli O
/ Bacteria_B
lactobacilli O
1 O
: O
248 O
) O
, O
where O
five O
- O
times O
reduction O
( O
or O
0 O
. O
7 O
log O
) O
was O
observed O
. O

When O
adhesion O
to O
tissue O
derived O
from O
pigs O
' O
jejunum O
was O
tested O
, O
concentration O
of O
E O
. O
coli O
was O
constant O
( O
6 O
. O
9 O
+ O
/ O
- O
0 O
. O
14 O
x O
10 O
( O
7 O
) O
cfu O
/ O
ml O
) O
, O
while O
the O
concentration O
of O
Lb O
. O

gasseri O
K O
7 O
was O
5 O
. O
9 O
x O
10 O
( O
7 O
) O
and O
1 O
. O
3 O
x O
10 O
( O
7 O
) O
cfu O
/ O
ml O
in O
two O
independent O
experiments O
, O
respectively O
. O

The O
adhesion O
of O
E O
. O
coli O
and O
Lb O
. O

gasseri O
K O
7 O
cells O
to O
jejunal O
mucosa O
was O
similar O
( O
1 O
. O
0 O
+ O
/ O
- O
0 O
. O
17 O
x O
10 O
( O
6 O
) O
and O
1 O
. O
54 O
+ O
/ O
- O
0 O
. O
10 O
x O
10 O
( O
6 O
) O
cfu O
/ O
cm O
( O
2 O
) O
) O
when O
the O
concentrations O
of O
single O
strains O
in O
suspensions O
were O
approximately O
the O
same O
. O

No O
significant O
competition O
, O
exclusion O
or O
displacement O
of O
E O
. O
coli O
by O
lactobacilli O
was O
observed O
on O
jejunal O
tissue O
. O

In O
conclusion O
, O
Lb O
. O

gasseri O
K O
7 O
was O
found O
to O
be O
effective O
in O
reducing O
E O
. O
coli O
adhesion O
to O
Caco O
- O
2 O
enterocytes O
, O
but O
it O
was O
not O
able O
to O
do O
so O
in O
ex O
vivo O
conditions O
tested O
for O
pig O
jejunal O
tissue O
. O

Challenges O
in O
the O
control O
of O
gonorrhea O
in O
South O
America O
and O
the O
Caribbean O
: O
monitoring O
the O
development O
of O
resistance O
to O
antibiotics O
. O

: O
The O
objective O
of O
this O
study O
was O
to O
ascertain O
the O
antimicrobial O
susceptibility O
of O
Neisseria Bacteria_B
gonorrhoeae Bacteria_I
isolates O
from O
6 O
South O
American O
and O
13 O
Caribbean O
countries O
participating O
in O
the O
Gonococcal O
Antimicrobial O
Surveillance O
Program O
( O
GASP O
) O
from O
1990 O
to O
1999 O
. O

: O
A O
GASP O
network O
of O
laboratories Habitat_B
was O
launched O
in O
the O
Americas O
and O
the O
Caribbean O
during O
the O
1990s O
. O

Standardized O
methods O
and O
interpretative O
criteria O
were O
established O
for O
the O
isolation O
of O
N Bacteria_B
. Bacteria_I
gonorrhoeae Bacteria_I
, O
strain O
identification O
, O
and O
determination O
, O
and O
quality O
control O
of O
antimicrobial O
susceptibility O
. O

: O
Two O
countries O
( O
Argentina O
and O
Uruguay O
) O
maintained O
continuous O
surveillance O
during O
the O
study O
period O
. O

Some O
countries O
gathered O
data O
periodically O
and O
several O
others O
were O
unable O
to O
initiate O
antimicrobial O
surveillance O
as O
a O
result O
of O
lack O
of O
resources O
. O

The O
percentage O
of O
penicillin O
- O
resistant O
N Bacteria_B
. Bacteria_I
gonorrhoeae Bacteria_I
isolated O
in O
the O
region O
over O
the O
decade O
varied O
considerably O
( O
1 O
. O
0 O
- O
11 O
. O
9 O
% O
carried O
chromosomal O
resistance O
and O
17 O
. O
9 O
- O
38 O
. O
8 O
% O
produced O
beta O
- O
lactamase O
) O
with O
an O
overall O
trend O
to O
declining O
numbers O
of O
penicillin O
- O
resistant O
isolates O
. O

For O
tetracycline O
, O
7 O
. O
4 O
% O
to O
36 O
. O
3 O
% O
carried O
chromosomal O
resistance O
, O
whereas O
12 O
. O
0 O
% O
to O
27 O
. O
4 O
% O
carried O
plasmid O
- O
mediated O
resistance O
. O

There O
were O
no O
reports O
of O
ciprofloxacin O
- O
resistant O
isolates O
, O
although O
N Bacteria_B
. Bacteria_I
gonorrhoeae Bacteria_I
with O
decreased O
susceptibility O
to O
ciprofloxacin O
and O
azithromycin O
as O
well O
as O
spectinomycin O
- O
resistant O
isolates O
were O
identified O
in O
some O
countries O
. O

Isolation O
of O
Helicobacter Bacteria_B
pullorum Bacteria_I
from O
patients Habitat_B
with Habitat_I
enteritis Habitat_I
. O

Helicobacter Bacteria_B
pullorum Bacteria_I
, O
recently O
described O
as O
sp O
. O

nov O
. O
, O
is O
commonly O
isolated O
from O
asymptomatic Habitat_B
poultry Habitat_I
. O

Two O
cases O
of O
human Habitat_B
enteritis O
associated O
with O
H Bacteria_B
. Bacteria_I
pullorum Bacteria_I
, O
one O
of O
them O
in O
an O
immunocompromised Habitat_B
patient Habitat_I
, O
are O
reported O
. O

Problems O
in O
the O
correct O
species O
identification O
by O
means O
of O
phenotypic O
and O
genotypic O
methods O
are O
discussed O
and O
for O
the O
first O
time O
a O
fatty O
acid O
pattern O
of O
Helicobacter Bacteria_B
pullorum Bacteria_I
is O
presented O
. O

Maintenance O
energy O
requirement O
: O
what O
is O
required O
for O
stasis O
survival O
of O
Escherichia Bacteria_B
coli Bacteria_I
? O

Little O
is O
known O
about O
how O
the O
energy O
of O
maintenance O
is O
generated O
in O
a O
cell O
supporting O
its O
persistence O
solely O
on O
endogenous O
carbon O
material O
, O
and O
what O
this O
energy O
is O
used O
for O
. O

However O
, O
it O
is O
clear O
that O
the O
endogenous O
metabolism O
of O
Escherichia Bacteria_B
coli Bacteria_I
cells O
held O
in O
the O
absence O
of O
exogenous O
carbon O
includes O
de O
novo O
protein O
synthesis O
, O
and O
that O
this O
synthesis O
is O
required O
for O
the O
maintenance O
of O
the O
growth O
- O
arrested O
cell O
. O

Recent O
findings O
suggest O
that O
several O
genes O
/ O
proteins O
responding O
to O
carbon O
starvation O
are O
themselves O
involved O
in O
reorganizing O
and O
modulating O
catabolic O
flux O
, O
while O
others O
form O
an O
integral O
part O
of O
a O
defense O
system O
aimed O
at O
avoiding O
the O
damaging O
effects O
of O
ongoing O
respiratory O
activity O
. O

A O
significant O
fraction O
of O
the O
energy O
of O
maintenance O
is O
suggested O
to O
be O
required O
to O
prevent O
the O
denaturation O
and O
spontaneous O
aging O
of O
proteins O
during O
stasis O
. O

Previous O
infection O
with O
Helicobacter Bacteria_B
pylori Bacteria_I
is O
the O
primary O
determinant O
of O
spontaneous O
gastric Habitat_B
hypoacidity O
in O
human Habitat_B
immunodeficiency Habitat_I
virus Habitat_I
- Habitat_I
infected Habitat_I
outpatients Habitat_I
. O

To O
investigate O
the O
incidence O
and O
demographics O
of O
gastric Habitat_B
hypoacidity O
among O
persons Habitat_B
infected Habitat_I
with Habitat_I
human Habitat_I
immunodeficiency Habitat_I
virus Habitat_I
( O
HIV O
) O
, O
146 O
asymptomatic Habitat_B
subjects Habitat_I
were O
evaluated O
with O
use O
of O
a O
radiotelemetry O
device O
( O
Heidelberg O
capsule O
) O
. O

Gastric Habitat_B
hypoacidity O
( O
minimum O
gastric Habitat_B
pH O
of O
> O
or O
= O
3 O
) O
occurred O
in O
24 O
subjects O
( O
17 O
% O
) O
. O

Demographic O
characteristics O
, O
CD4 Habitat_B
cell Habitat_I
counts O
, O
and O
Helicobacter Bacteria_B
pylori Bacteria_I
serological O
status O
were O
evaluated O
for O
an O
association O
with O
gastric Habitat_B
pH O
. O

Subjects Habitat_B
with Habitat_I
hypoacidity Habitat_I
were O
more O
likely O
to O
have O
positive O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
serology O
than O
were O
subjects Habitat_B
without Habitat_I
hypoacidity Habitat_I
( O
15 O
of O
24 O
vs O
. O
23 O
of O
74 O
, O
respectively O
; O
P O
= O
. O
004 O
) O
. O

Multivariate O
analysis O
indicated O
that O
a O
positive O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
serology O
was O
the O
most O
significant O
predictor O
of O
hypoacidity O
, O
accounting O
for O
an O
increase O
in O
gastric Habitat_B
pH O
of O
39 O
% O
. O

A O
history O
of O
injection O
drug O
use O
, O
heterosexual O
transmission O
of O
HIV O
, O
and O
male Habitat_B
gender Habitat_I
were O
also O
associated O
with O
an O
elevated O
gastric Habitat_B
pH O
. O

CD4 Habitat_B
cell Habitat_I
counts O
did O
not O
contribute O
to O
predictions O
of O
gastric Habitat_B
pH O
. O

A O
history O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
is O
relatively O
common O
in O
HIV O
- O
positive O
black O
and O
Hispanic O
populations O
and O
is O
a O
predictor O
of O
gastric Habitat_B
pH O
. O

Recurrence O
of O
Pelecypod Habitat_B
- O
associated O
cholera O
in O
Sardinia O
. O

From O
Oct O
. O
30 O
to O
Nov O
. O
7 O
, O
1979 O
, O
10 O
people Habitat_B
in O
the O
Sardinian O
province O
of O
Cagliari O
had O
onset O
of O
bacteriologically O
confirmed O
cholera O
. O

Two O
symptom O
- O
free O
excretors O
of O
Vibrio Bacteria_B
cholerae Bacteria_I
O Bacteria_I
: Bacteria_I
1 Bacteria_I
were O
detected O
in O
household Habitat_B
contacts Habitat_I
of Habitat_I
the Habitat_I
patients Habitat_I
. O

There O
were O
no O
deaths O
. O

All O
but O
1 O
of O
the O
12 O
people Habitat_B
with Habitat_I
V Habitat_I
. Habitat_I
cholerae Habitat_I
O Habitat_I
: Habitat_I
1 Habitat_I
infection Habitat_I
gave O
a O
history O
of O
recent O
consumption O
of O
marine Habitat_B
bivalves Habitat_I
known O
locally O
as O
arselle Habitat_B
( O
pelecypods Habitat_B
) O
. O

Triplicate O
matched O
neighbourhood O
controls O
for O
each O
of O
the O
first O
7 O
cases O
identified O
were O
also O
interviewed O
; O
none O
had O
recently O
eaten O
arselle Habitat_B
. O

V Bacteria_B
. Bacteria_I
cholerae Bacteria_I
O Bacteria_I
: Bacteria_I
1 Bacteria_I
was O
also O
recovered O
from O
samples O
of O
water Habitat_B
and O
bivalves Habitat_B
obtained O
from O
a O
lagoon Habitat_B
on Habitat_I
the Habitat_I
outskirts Habitat_I
of Habitat_I
the Habitat_I
city Habitat_I
of Habitat_I
Cagliari Habitat_I
. O

Arselle Habitat_B
had O
also O
been O
implicated O
as O
the O
vehicle O
of O
transmission O
in O
1973 O
in O
the O
last O
outbreak O
of O
cholera O
in O
Sardinia O
. O

It O
seems O
unlikely O
that O
cholera O
transmission O
had O
persisted O
locally O
in O
the O
interim O
. O

Widespread O
acquisition O
of O
antimicrobial O
resistance O
among O
Campylobacter Bacteria_B
isolates O
from O
UK Habitat_B
retail Habitat_I
poultry Habitat_I
and O
evidence O
for O
clonal O
expansion O
of O
resistant O
lineages O
. O

Antimicrobial O
resistance O
is O
increasing O
among O
clinical Habitat_B
Campylobacter Bacteria_B
cases O
and O
is O
common O
among O
isolates O
from O
other O
sources O
, O
specifically O
retail Habitat_B
poultry Habitat_I
- O
a O
major O
source O
of O
human Habitat_B
infection O
. O

In O
this O
study O
the O
antimicrobial O
susceptibility O
of O
isolates O
from O
a O
UK O
- O
wide O
survey O
of O
Campylobacter Bacteria_B
in O
retail Habitat_B
poultry Habitat_I
in O
2001 O
and O
2004 O
- O
5 O
was O
investigated O
. O

The O
occurrence O
of O
phenotypes O
resistant O
to O
tetracycline O
, O
quinolones O
( O
ciprofloxacin O
and O
naladixic O
acid O
) O
, O
erythromycin O
, O
chloramphenicol O
and O
aminoglycosides O
was O
quantified O
. O

This O
was O
compared O
with O
a O
phylogeny O
for O
these O
isolates O
based O
upon O
Multi O
Locus O
Sequence O
Typing O
( O
MLST O
) O
to O
investigate O
the O
pattern O
of O
antimicrobial O
resistance O
acquisition O
. O

Antimicrobial O
resistance O
was O
present O
in O
all O
lineage O
clusters O
, O
but O
statistical O
testing O
showed O
a O
non O
- O
random O
distribution O
. O

Erythromycin O
resistance O
was O
associated O
with O
Campylobacter Bacteria_B
coli Bacteria_I
. O

For O
all O
antimicrobials O
tested O
, O
resistant O
isolates O
were O
distributed O
among O
relatively O
distant O
lineages O
indicative O
of O
widespread O
acquisition O
. O

There O
was O
also O
evidence O
of O
clustering O
of O
resistance O
phenotypes O
within O
lineages O
; O
indicative O
of O
local O
expansion O
of O
resistant O
strains O
. O

These O
results O
are O
consistent O
with O
the O
widespread O
acquisition O
of O
antimicrobial O
resistance O
among O
chicken Habitat_B
associated O
Campylobacter Bacteria_B
isolates O
, O
either O
through O
mutation O
or O
horizontal O
gene O
transfer O
, O
and O
the O
expansion O
of O
these O
lineages O
as O
a O
proportion O
of O
the O
population O
. O

As O
Campylobacter Bacteria_B
are O
not O
known O
to O
multiply O
outside O
of O
the O
host O
and O
long O
- O
term O
carriage O
in O
humans Habitat_B
is O
extremely O
infrequent O
in O
industrialized O
countries O
, O
the O
most O
likely O
location O
for O
the O
proliferation O
of O
resistant O
lineages O
is O
in O
farmed Habitat_B
chickens Habitat_I
. O

Structure O
of O
MurNAc O
6 O
- O
phosphate O
hydrolase O
( O
MurQ O
) O
from O
Haemophilus Bacteria_B
influenzae Bacteria_I
with O
a O
bound O
inhibitor O
. O

The O
breakdown O
and O
recycling O
of O
peptidoglycan O
, O
an O
essential O
polymeric O
cell O
structure O
, O
occur O
in O
a O
number O
of O
bacterial O
species O
. O

A O
key O
enzyme O
in O
the O
recycling O
pathway O
of O
one O
of O
the O
components O
of O
the O
peptidoglycan O
layer O
, O
N O
- O
acetylmuramic O
acid O
( O
MurNAc O
) O
, O
is O
MurNAc O
6 O
- O
phosphate O
hydrolase O
( O
MurQ O
) O
. O

This O
enzyme O
catalyzes O
the O
cofactor O
- O
independent O
cleavage O
of O
a O
relatively O
nonlabile O
ether O
bond O
and O
presents O
an O
interesting O
target O
for O
mechanistic O
studies O
. O

Open O
chain O
product O
and O
substrate O
analogues O
were O
synthesized O
and O
tested O
as O
competitive O
inhibitors O
( O
K O
( O
is O
) O
values O
of O
1 O
. O
1 O
± O
0 O
. O
3 O
and O
0 O
. O
23 O
± O
0 O
. O
02 O
mM O
, O
respectively O
) O
of O
the O
MurNAc O
6P O
hydrolase O
from O
Escherichia Bacteria_B
coli Bacteria_I
( O
MurQ O
- O
EC O
) O
. O

To O
identify O
the O
roles O
of O
active O
site O
residues O
that O
are O
important O
for O
catalysis O
, O
the O
substrate O
analogue O
was O
cocrystallized O
with O
the O
MurNAc O
6P O
hydrolase O
from O
Haemophilus Bacteria_B
influenzae Bacteria_I
( O
MurQ O
- O
HI O
) O
that O
was O
amenable O
to O
crystallographic O
studies O
. O

The O
cocrystal O
structure O
of O
MurQ O
- O
HI O
with O
the O
substrate O
analogue O
showed O
that O
Glu89 O
was O
located O
in O
the O
proximity O
of O
both O
the O
C2 O
atom O
and O
the O
oxygen O
at O
the O
C3 O
position O
of O
the O
bound O
inhibitor O
and O
that O
no O
other O
potential O
acid O
/ O
base O
residue O
that O
could O
act O
as O
an O
active O
site O
acid O
/ O
base O
was O
located O
in O
the O
vicinity O
. O

The O
conserved O
residues O
Glu120 O
and O
Lys239 O
were O
found O
within O
hydrogen O
bonding O
distance O
of O
the O
C5 O
hydroxyl O
group O
and O
C6 O
phosphate O
group O
, O
suggesting O
that O
they O
play O
a O
role O
in O
substrate O
binding O
and O
ring O
opening O
. O

Combining O
these O
results O
with O
previous O
biochemical O
data O
, O
we O
propose O
a O
one O
- O
base O
mechanism O
of O
action O
in O
which O
Glu89 O
functions O
to O
both O
deprotonate O
at O
the O
C2 O
position O
and O
assist O
in O
the O
departure O
of O
the O
lactyl O
ether O
at O
the O
C3 O
position O
. O

This O
same O
residue O
would O
serve O
to O
deprotonate O
the O
incoming O
water O
and O
reprotonate O
the O
enolate O
in O
the O
second O
half O
of O
the O
catalytic O
cycle O
. O

Usage O
of O
signaling O
in O
neurodegeneration O
and O
regeneration O
of O
peripheral Habitat_B
nerves Habitat_I
by O
leprosy O
bacteria O
. O

Multiple O
signaling O
pathways O
play O
key O
regulatory O
roles O
during O
the O
development O
of O
peripheral Habitat_B
nervous Habitat_I
system Habitat_I
( O
PNS Habitat_B
) O
and O
also O
in O
neuroregeneration O
process O
following O
nerve Habitat_B
degeneration O
. O

Schwann Habitat_B
cells Habitat_I
, O
the O
glial Habitat_B
cells Habitat_I
of Habitat_I
the Habitat_I
PNS Habitat_I
, O
by O
interacting O
with O
neuronal O
( O
axonal O
) O
ligands O
, O
mainly O
neuregulins O
via O
receptor O
tyrosine O
kinase O
( O
RTK O
) O
complex O
, O
ErbB2 O
/ O
ErbB3 O
, O
initiate O
intracellular O
signaling O
pathways O
to O
drive O
proliferation O
and O
differentiation O
of O
Schwann Habitat_B
cells Habitat_I
, O
both O
during O
development O
and O
the O
process O
of O
regeneration O
and O
re O
- O
myelination O
after O
nerve Habitat_B
injury Habitat_I
. O

One O
of O
the O
major O
signaling O
kinases O
, O
extracellular O
signal O
- O
regulated O
kinase O
- O
1 O
/ O
2 O
( O
ERK1 O
/ O
2 O
) O
, O
that O
is O
also O
a O
downstream O
signaling O
pathway O
of O
neuregulin O
- O
ErbB2 O
/ O
ErbB3 O
activation O
, O
has O
been O
identified O
as O
a O
key O
regulator O
of O
Schwann Habitat_B
cell Habitat_I
proliferation O
, O
differentiation O
, O
demyelination O
and O
nerve Habitat_B
regeneration O
. O

Recent O
studies O
have O
provided O
evidence O
that O
the O
bacterium O
that O
causes O
human Habitat_B
leprosy O
, O
Mycobacterium Bacteria_B
leprae Bacteria_I
that O
has O
a O
unique O
capacity O
to O
invade O
Schwann Habitat_B
cells Habitat_I
of Habitat_I
the Habitat_I
adult Habitat_I
PNS Habitat_I
, O
utilizes O
the O
neuregulin O
- O
ErbB2 O
/ O
ErbB3 O
associated O
signaling O
network O
to O
the O
bacterial O
advantage O
. O

M Bacteria_B
. Bacteria_I
leprae Bacteria_I
directly O
bind O
to O
ErbB2 O
on O
myelinated Habitat_B
Schwann Habitat_I
cells Habitat_I
and O
activate O
the O
RTK O
by O
a O
novel O
route O
that O
bypasses O
the O
classical O
neuregulin O
/ O
growth O
factor O
- O
induced O
ErbB2 O
- O
ErbB3 O
heterodimerization O
, O
and O
subsequently O
induce O
downstream O
the O
canonical O
Erk1 O
/ O
2 O
signaling O
, O
leading O
to O
myelin O
breakdown O
and O
subsequent O
axonal O
damage O
. O

This O
initial O
injury Habitat_B
provides O
a O
survival O
advantage O
for O
M Bacteria_B
. Bacteria_I
leprae Bacteria_I
as O
it O
induces O
de O
- O
differentiation O
and O
generates O
myelin Habitat_B
- Habitat_I
free Habitat_I
cells Habitat_I
, O
which O
are O
highly O
susceptible O
to O
M Bacteria_B
. Bacteria_I
leprae Bacteria_I
invasion O
and O
promote O
bacterial O
survival O
. O

Once O
invaded O
M Bacteria_B
. Bacteria_I
leprae Bacteria_I
activate O
Erk1 O
/ O
2 O
via O
a O
non O
- O
canonical O
pathway O
and O
subsequently O
increase O
the O
cell Habitat_B
proliferation O
and O
maintain O
the O
infected Habitat_B
cells Habitat_I
in O
de O
- O
differentiated O
state O
, O
thereby O
preventing O
remyelination O
. O

Therefore O
, O
by O
subverting O
major O
RTKs O
and O
signaling O
pathways O
in O
adult Habitat_B
Schwann Habitat_I
cells Habitat_I
M Bacteria_B
. Bacteria_I
leprae Bacteria_I
appear O
to O
propagate O
the O
bacterial O
niche O
and O
maintain O
survival O
within O
the O
PNS Habitat_B
. O

These O
studies O
may O
also O
provide O
new O
insights O
into O
our O
understanding O
of O
signaling O
mechanisms O
involve O
in O
both O
neurodegeneration O
and O
neuroregeneration O
. O

Impact O
of O
intracranial O
pressure O
monitor O
prophylaxis O
on O
central Habitat_B
nervous Habitat_I
system Habitat_I
infections O
and O
bacterial O
multi O
- O
drug O
resistance O
. O

Routine O
intracranial O
pressure O
monitor O
( O
ICP O
) O
prophylaxis O
is O
not O
practiced O
at O
our O
institution O
. O

Nevertheless O
, O
some O
patients Habitat_B
receive O
de O
facto O
prophylaxis O
as O
a O
result O
of O
the O
use O
of O
antibiotics O
for O
injuries O
such O
as O
open O
or O
facial Habitat_B
fractures O
. O

We O
tested O
the O
hypothesis O
that O
prophylactic O
antibiotics O
do O
not O
reduce O
the O
incidence O
of O
central Habitat_B
nervous Habitat_I
system Habitat_I
( O
CNS Habitat_B
) O
infections O
but O
instead O
are O
associated O
with O
the O
acquisition O
of O
multi O
- O
drug O
resistant O
( O
MDR O
) O
bacterial O
infections O
. O

Patients Habitat_B
admitted O
to O
the O
trauma Habitat_B
intensive Habitat_I
care Habitat_I
unit Habitat_I
( O
TICU Habitat_B
) O
from O
January O
, O
2001 O
through O
December O
, O
2004 O
with O
blunt O
, O
non O
- O
operative O
traumatic O
brain Habitat_B
injury Habitat_I
who O
were O
managed O
solely O
with O
an O
ICP O
monitor O
were O
identified O
from O
our O
trauma O
registry O
and O
divided O
into O
two O
groups O
: O
( O
1 O
) O
Those O
receiving O
no O
antibiotics O
prior O
to O
or O
during O
ICP O
monitoring O
( O
NONE O
; O
n O
= O
71 O
) O
; O
and O
( O
2 O
) O
those O
already O
receiving O
antibiotics O
at O
the O
time O
of O
ICP O
monitor O
insertion O
( O
PRO O
; O
n O
= O
84 O
) O
. O

Groups O
were O
stratified O
on O
the O
basis O
of O
age O
, O
Injury O
Severity O
Score O
( O
ISS O
) O
, O
Glasgow O
Coma O
Scale O
( O
GCS O
) O
Score O
, O
base O
excess O
( O
BE O
) O
, O
ICP O
days O
, O
transfusions O
in O
24 O
h O
, O
ICU Habitat_B
days O
, O
ventilator O
days O
, O
head O
Abbreviated O
Injury O
Score O
( O
AIS O
) O
, O
and O
chest O
AIS O
. O

The O
study O
groups O
did O
not O
differ O
with O
respect O
to O
age O
, O
ISS O
, O
GCS O
, O
BE O
, O
ICP O
days O
, O
24 O
- O
h O
transfusions O
, O
ICU Habitat_B
days O
, O
ventilator O
days O
, O
head O
AIS O
, O
or O
length O
of O
stay O
. O

In O
all O
, O
183 O
patients Habitat_B
were O
identified O
, O
of O
whom O
28 O
died O
within O
seven O
days O
and O
were O
excluded O
from O
the O
analysis O
. O

All O
patients Habitat_B
were O
followed O
until O
discharge O
for O
both O
CNS Habitat_B
infections O
and O
subsequent O
infectious O
complications O
. O

Only O
two O
patients Habitat_B
, O
both O
in O
the O
PRO O
group O
, O
developed O
CNS Habitat_B
infection O
. O

Both O
infectious O
complications O
( O
0 O
. O
7 O
vs O
1 O
. O
4 O
per O
patient Habitat_B
; O
p O
< O
0 O
. O
05 O
) O
and O
infections O
secondary O
to O
MDR O
pathogens O
( O
0 O
. O
03 O
vs O
. O
0 O
. O
33 O
per O
patient Habitat_B
; O
p O
< O
0 O
. O
01 O
) O
were O
significantly O
more O
common O
in O
the O
PRO O
group O
. O

Twenty O
- O
nine O
percent O
of O
the O
ventilator O
- O
associated O
pneumonias O
and O
33 O
% O
of O
the O
blood Habitat_B
stream Habitat_I
infections O
in O
the O
PRO O
group O
were O
MDR O
, O
whereas O
only O
two O
blood Habitat_B
stream Habitat_I
infections O
in O
the O
NONE O
group O
( O
4 O
% O
of O
the O
total O
infections O
) O
were O
MDR O
. O

The O
routine O
use O
of O
prophylactic O
antibiotics O
for O
ICP O
monitor O
insertion O
is O
not O
warranted O
. O

This O
practice O
does O
not O
reduce O
the O
CNS Habitat_B
infection O
rate O
and O
is O
associated O
with O
more O
MDR O
pathogens O
in O
any O
subsequent O
infectious O
complications O
. O

Application O
of O
ozone Habitat_B
for O
enhancing O
the O
microbiological O
safety O
and O
quality O
of O
foods Habitat_B
: O
a O
review O
. O

Ozone Habitat_B
( O
O3 Habitat_B
) O
is O
a O
strong O
antimicrobial O
agent O
with O
numerous O
potential O
applications O
in O
the O
food Habitat_B
industry O
. O

High O
reactivity O
, O
penetrability O
, O
and O
spontaneous O
decomposition O
to O
a O
nontoxic O
product O
( O
i O
. O
e O
. O
, O
O2 O
) O
make O
ozone Habitat_B
a O
viable O
disinfectant O
for O
ensuring O
the O
microbiological O
safety O
of O
food Habitat_B
products Habitat_I
. O

Ozone Habitat_B
has O
been O
used O
for O
decades O
in O
many O
countries O
and O
recently O
, O
the O
generally O
recognized O
as O
safe O
( O
GRAS O
) O
status O
of O
this O
gas O
has O
been O
reaffirmed O
in O
the O
United O
States O
. O

Ozone Habitat_B
, O
in O
the O
gaseous O
or O
aqueous O
phases O
, O
is O
effective O
against O
the O
majority O
of O
microorganisms O
tested O
by O
numerous O
research O
groups O
. O

Relatively O
low O
concentrations O
of O
ozone Habitat_B
and O
short O
contact O
time O
are O
sufficient O
to O
inactivate O
bacteria O
, O
molds O
, O
yeasts O
, O
parasites O
, O
and O
viruses O
. O

However O
, O
rates O
of O
inactivation O
are O
greater O
in O
ozone Habitat_B
demand O
- O
free O
systems O
than O
when O
the O
medium O
contains O
oxidizable O
organic O
substances O
. O

Susceptibility O
of O
microorganisms O
to O
ozone Habitat_B
also O
varies O
with O
the O
physiological O
state O
of O
the O
culture O
, O
pH O
of O
the O
medium O
, O
temperature O
, O
humidity O
, O
and O
presence O
of O
additives Habitat_B
( O
e O
. O
g O
. O
, O
acids Habitat_B
, O
surfactants Habitat_B
, O
and O
sugars Habitat_B
) O
. O

Ozone Habitat_B
applications O
in O
the O
food Habitat_B
industry O
are O
mostly O
related O
to O
decontamination O
of O
product Habitat_B
surface Habitat_I
and O
water Habitat_B
treatment O
. O

Ozone Habitat_B
has O
been O
used O
with O
mixed O
success O
to O
inactivate O
contaminant Habitat_B
microflora Habitat_I
on O
meat Habitat_B
, O
poultry Habitat_B
, O
eggs Habitat_B
, O
fish Habitat_B
, O
fruits Habitat_B
, O
vegetables Habitat_B
, O
and O
dry Habitat_B
foods Habitat_I
. O

The O
gas O
also O
is O
useful O
in O
detoxification O
and O
elimination O
of O
mycotoxins O
and O
pesticide Habitat_B
residues Habitat_I
from O
some O
agricultural Habitat_B
products Habitat_I
. O

Excessive O
use O
of O
ozone Habitat_B
, O
however O
, O
may O
cause O
oxidation O
of O
some O
ingredients O
on O
food Habitat_B
surface Habitat_I
. O

This O
usually O
results O
in O
discoloration O
and O
deterioration O
of O
food Habitat_B
flavor O
. O

Additional O
research O
is O
needed O
to O
elucidate O
the O
kinetics O
and O
mechanisms O
of O
microbial O
inactivation O
by O
ozone Habitat_B
and O
to O
optimize O
its O
use O
in O
food Habitat_B
applications O
. O

Amino O
acid O
requirements O
of O
strains O
of O
Chlamydia Bacteria_B
trachomatis Bacteria_I
and O
C Bacteria_B
. Bacteria_I
psittaci Bacteria_I
growing O
in O
McCoy Habitat_B
cells Habitat_I
: O
relationship O
with O
clinical Habitat_B
syndrome O
and O
host O
origin O
. O

The O
effects O
of O
omission O
of O
individual O
amino O
acids O
from O
growth O
medium O
on O
the O
multiplication O
of O
a O
range O
of O
Chlamydia Bacteria_B
trachomatis Bacteria_I
and O
C Bacteria_B
. Bacteria_I
psittaci Bacteria_I
strains O
in O
cycloheximide Habitat_B
- Habitat_I
treated Habitat_I
McCoy Habitat_I
cells Habitat_I
have O
been O
assessed O
. O

Differences O
in O
requirements O
were O
revealed O
which O
for O
C Bacteria_B
. Bacteria_I
trachomatis Bacteria_I
strains O
correlated O
with O
clinical Habitat_B
syndrome O
and O
for O
C Bacteria_B
. Bacteria_I
psittaci Bacteria_I
with O
host O
origin O
. O

All O
11 O
strains O
of O
C Bacteria_B
. Bacteria_I
trachomatis Bacteria_I
examined O
showed O
a O
requirement O
for O
addition O
of O
histidine O
to O
the O
medium O
; O
this O
was O
not O
shown O
by O
any O
of O
four O
C Bacteria_B
. Bacteria_I
psittaci Bacteria_I
strains O
. O

Among O
the O
strains O
of O
C Bacteria_B
. Bacteria_I
trachomatis Bacteria_I
, O
three O
from O
cases Habitat_B
of Habitat_I
trachoma Habitat_I
, O
representing O
serotypes Bacteria_B
A Bacteria_I
, O
B O
and O
C O
, O
showed O
a O
distinctive O
requirement O
for O
the O
addition O
of O
tryptophan O
to O
the O
medium O
, O
whilst O
six O
strains O
of O
oculogenital Habitat_B
origin Habitat_I
, O
representing O
serotypes Bacteria_B
D Bacteria_I
- Bacteria_I
I Bacteria_I
, O
exhibited O
no O
requirement O
for O
tryptophan O
or O
methionine O
; O
a O
lymphogranuloma O
venereum O
and O
a O
' O
fast O
variant O
' O
strain O
both O
showed O
a O
requirement O
for O
methionine O
. O

Of O
the O
four O
C Bacteria_B
. Bacteria_I
psittaci Bacteria_I
strains O
from O
different O
hosts O
, O
three O
showed O
distinct O
patterns O
of O
amino O
acid O
requirements O
. O

All O
chlamydiae Bacteria_B
required O
the O
addition O
of O
valine O
to O
medium O
and O
the O
majority O
required O
leucine O
, O
phenylalanine O
and O
also O
glutamine O
. O

Rapid O
detection O
of O
eight O
causative O
pathogens O
for O
the O
diagnosis O
of O
bacterial O
meningitis O
by O
real O
- O
time O
PCR O
. O

We O
aimed O
to O
detect O
causative O
pathogens O
in O
cerebrospinal Habitat_B
fluid Habitat_I
( O
CSF Habitat_B
) O
collected O
from O
patients Habitat_B
diagnosed Habitat_I
with Habitat_I
bacterial Habitat_I
meningitis Habitat_I
by O
real O
- O
time O
polymerase O
chain O
reaction O
( O
PCR O
) O
. O

In O
addition O
to O
Streptococcus Bacteria_B
pneumoniae Bacteria_I
, O
Haemophilus Bacteria_B
influenzae Bacteria_I
, O
and O
Mycoplasma Bacteria_B
pneumoniae Bacteria_I
described O
previously O
, O
five O
other O
pathogens O
, O
Neisseria Bacteria_B
meningitidis Bacteria_I
, O
Escherichia Bacteria_B
coli Bacteria_I
, O
Streptococcus Bacteria_B
agalactiae Bacteria_I
, O
Staphylococcus Bacteria_B
aureus Bacteria_I
, O
and O
Listeria Bacteria_B
monocytogenes Bacteria_I
, O
were O
targeted O
, O
based O
on O
a O
large O
- O
scale O
surveillance O
in O
Japan O
. O

Results O
in O
CSF Habitat_B
from Habitat_I
neonates Habitat_I
and Habitat_I
children Habitat_I
( O
n O
= O
150 O
) O
, O
and O
from O
adults Habitat_B
( O
n O
= O
18 O
) O
analyzed O
by O
real O
- O
time O
PCR O
with O
molecular O
beacon O
probes O
were O
compared O
with O
those O
of O
conventional O
culturing O
. O

The O
total O
time O
from O
DNA O
extraction O
from O
CSF Habitat_B
to O
PCR O
analysis O
was O
1 O
. O
5 O
h O
. O
The O
limit O
of O
detection O
for O
these O
pathogens O
ranged O
from O
5 O
copies O
to O
28 O
copies O
per O
tube O
. O

Nonspecific O
positive O
reactions O
were O
not O
recognized O
for O
37 O
microorganisms O
in O
clinical Habitat_B
isolates O
as O
a O
negative O
control O
. O

The O
pathogens O
were O
detected O
in O
72 O
. O
0 O
% O
of O
the O
samples O
by O
real O
- O
time O
PCR O
, O
but O
in O
only O
48 O
. O
2 O
% O
by O
culture O
, O
although O
the O
microorganisms O
were O
completely O
concordant O
. O

With O
the O
real O
- O
time O
PCR O
, O
the O
detection O
rate O
of O
H Bacteria_B
. Bacteria_I
influenzae Bacteria_I
from O
CSF Habitat_B
was O
high O
, O
at O
45 O
. O
2 O
% O
, O
followed O
by O
S Bacteria_B
. Bacteria_I
pneumoniae Bacteria_I
( O
21 O
. O
4 O
% O
) O
, O
S Bacteria_B
. Bacteria_I
agalactiae Bacteria_I
( O
2 O
. O
4 O
% O
) O
, O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
( O
1 O
. O
8 O
% O
) O
, O
L Bacteria_B
. Bacteria_I
monocytogenes Bacteria_I
( O
0 O
. O
6 O
% O
) O
, O
and O
M Bacteria_B
. Bacteria_I
pneumoniae Bacteria_I
( O
0 O
. O
6 O
% O
) O
. O

The O
detection O
rate O
with O
PCR O
was O
significantly O
better O
than O
that O
with O
cultures O
in O
patients Habitat_B
with Habitat_I
antibiotic Habitat_I
administration Habitat_I
( O
chi2 O
= O
18 O
. O
3182 O
; O
P O
= O
0 O
. O
0000 O
) O
. O

In O
conclusion O
, O
detection O
with O
real O
- O
time O
PCR O
is O
useful O
for O
rapidly O
identifying O
the O
causative O
pathogens O
of O
meningitis O
and O
for O
examining O
the O
clinical O
course O
of O
chemotherapy O
. O

Construction O
of O
an O
attenuated O
Pseudomonas Bacteria_B
fluorescens Bacteria_I
strain O
and O
evaluation O
of O
its O
potential O
as O
a O
cross O
- O
protective O
vaccine Habitat_B
. O

Ferric O
uptake O
regulator O
( O
Fur O
) O
is O
a O
global O
transcription O
regulator O
that O
is O
ubiquitous O
to O
Gram O
- O
negative O
bacteria O
and O
regulates O
diverse O
biological O
processes O
, O
including O
iron O
uptake O
, O
cellular O
metabolism O
, O
stress O
response O
, O
and O
production O
of O
virulence O
determinants O
. O

As O
a O
result O
, O
for O
many O
pathogenic O
bacteria O
, O
Fur O
plays O
a O
crucial O
role O
in O
the O
course O
of O
infection O
and O
disease O
development O
. O

In O
this O
study O
, O
the O
fur O
gene O
was O
cloned O
from O
a O
pathogenic O
Pseudomonas Bacteria_B
fluorescens Bacteria_I
strain Bacteria_I
, Bacteria_I
TSS Bacteria_I
, O
isolated O
from O
diseased Habitat_B
Japanese Habitat_I
flounder Habitat_I
cultured Habitat_I
in Habitat_I
a Habitat_I
local Habitat_I
farm Habitat_I
. O

TSS Bacteria_B
Fur O
can O
partially O
complement O
the O
defective O
phenotype O
of O
an O
Escherichia Bacteria_B
coli Bacteria_I
fur O
mutant O
. O

A O
TSS Bacteria_B
fur Bacteria_I
null Bacteria_I
mutant Bacteria_I
, O
TFM Bacteria_B
, O
was O
constructed O
. O

Compared O
to O
TSS Bacteria_B
, O
TFM Bacteria_B
exhibits O
reduced O
growth O
ability O
, O
aberrant O
production O
of O
outer O
membrane O
proteins O
, O
decreased O
resistance O
against O
host Habitat_B
serum Habitat_I
bactericidal O
activity O
, O
impaired O
ability O
to O
disseminate O
in O
host Habitat_B
blood Habitat_I
and O
tissues O
, O
and O
drastic O
attenuation O
in O
overall O
bacterial O
virulence O
in O
a O
Japanese Habitat_B
flounder Habitat_I
infection O
model O
. O

When O
used O
as O
a O
live Habitat_B
vaccine Habitat_I
administered O
via O
the O
injection O
, O
immersion O
, O
and O
oral Habitat_B
routes O
, O
TFM Bacteria_B
affords O
high O
levels O
of O
protection O
upon O
Japanese Habitat_B
flounder Habitat_I
against O
not O
only O
P Bacteria_B
. Bacteria_I
fluorescens Bacteria_I
infection O
but O
also O
Aeromonas Bacteria_B
hydrophila Bacteria_I
infection O
. O

Furthermore O
, O
a O
plasmid O
, O
pJAQ O
, O
was O
constructed O
, O
which O
expresses O
the O
coding O
element O
of O
the O
Vibrio Bacteria_B
harveyi Bacteria_I
antigen O
AgaV O
- O
DegQ O
. O

TFM Bacteria_B
harboring O
pJAQ O
can O
secret O
AgaV O
- O
DegQ O
into O
the O
extracellular O
milieu O
. O

Vaccination O
of O
Japanese Habitat_B
flounder Habitat_I
with O
live O
TFM Bacteria_B
/ O
pJAQ O
elicited O
strong O
immunoprotection O
against O
both O
V Bacteria_B
. Bacteria_I
harveyi Bacteria_I
and O
A Bacteria_B
. Bacteria_I
hydrophila Bacteria_I
infections O
. O

Gingivomandibular Habitat_B
infection O
due O
to O
Mycobacterium Bacteria_B
kansasii Bacteria_I
in O
a O
patient Habitat_B
with Habitat_I
AIDS Habitat_I
. O

Presence O
of O
the O
fish Habitat_B
pathogen O
Vibrio Bacteria_B
salmonicida Bacteria_I
in O
fish Habitat_B
farm Habitat_I
sediments O
. O

The O
persistence O
of O
the O
fish Habitat_B
pathogen O
Vibrio Bacteria_B
salmonicida Bacteria_I
in O
fish Habitat_B
farm Habitat_I
sediments O
was O
studied O
by O
use O
of O
fluorescent O
- O
antibody O
techniques O
. O

The O
specificities O
of O
the O
monoclonal O
antibodies O
and O
polyclonal Habitat_B
rabbit Habitat_I
serum Habitat_I
used O
in O
the O
study O
were O
tested O
against O
a O
number O
of O
Vibrio Bacteria_B
strains O
, O
including O
4 O
isolates O
from O
intestinal Habitat_B
tracts Habitat_I
of Habitat_I
healthy Habitat_I
fish Habitat_I
and O
98 O
isolates O
from O
sediments Habitat_B
. O

V Bacteria_B
. Bacteria_I
salmonicida Bacteria_I
was O
detected O
in O
sediment Habitat_B
samples Habitat_I
from Habitat_I
diseased Habitat_I
farms Habitat_I
several O
months O
after O
an O
outbreak O
of O
the O
disease O
. O

The O
bacterium O
was O
also O
detected O
in O
a O
sediment Habitat_B
sample Habitat_I
from Habitat_I
a Habitat_I
disease Habitat_I
- Habitat_I
free Habitat_I
fish Habitat_I
farm Habitat_I
. O

No O
V Bacteria_B
. Bacteria_I
salmonicida Bacteria_I
could O
be O
detected O
in O
sediments Habitat_B
not O
influenced O
by O
fish Habitat_B
farming Habitat_I
. O

The O
number O
of O
positive O
samples O
was O
generally O
higher O
with O
application O
of O
rabbit Habitat_B
serum O
as O
opposed O
to O
use O
of O
monoclonal O
antibodies O
, O
indicating O
that O
the O
rabbit Habitat_B
serum Habitat_I
may O
cross O
- O
react O
with O
other O
bacteria O
. O

Annexin1 O
regulates O
DC Habitat_B
efferocytosis O
and O
cross O
- O
presentation O
during O
Mycobacterium Bacteria_B
tuberculosis Bacteria_I
infection O
. O

The O
phagocytosis O
of O
apoptotic Habitat_B
cells Habitat_I
and O
associated O
vesicles O
( O
efferocytosis O
) O
by O
DCs Habitat_B
is O
an O
important O
mechanism O
for O
both O
self O
tolerance O
and O
host O
defense O
. O

Although O
some O
of O
the O
engulfment O
ligands O
involved O
in O
efferocytosis O
have O
been O
identified O
and O
studied O
in O
vitro O
, O
the O
contributions O
of O
these O
ligands O
in O
vivo O
remain O
ill O
defined O
. O

Here O
, O
we O
determined O
that O
during O
Mycobacterium Bacteria_B
tuberculosis Bacteria_I
( O
Mtb Bacteria_B
) O
infection O
, O
the O
engulfment O
ligand O
annexin1 O
is O
an O
important O
mediator O
in O
DC Habitat_B
cross O
- O
presentation O
that O
increases O
efferocytosis O
in O
DCs Habitat_B
and O
intrinsically O
enhances O
the O
capacity O
of O
the O
DC Habitat_B
antigen O
- O
presenting O
machinery O
. O

Annexin1 Habitat_B
- Habitat_I
deficient Habitat_I
mice Habitat_I
were O
highly O
susceptible O
to O
Mtb Bacteria_B
infection O
and O
showed O
an O
impaired O
Mtb Bacteria_B
antigen O
- O
specific O
CD8 Habitat_B
+ Habitat_I
T Habitat_I
cell Habitat_I
response O
. O

Importantly O
, O
annexin1 O
expression O
was O
greatly O
downregulated O
in O
Mtb Habitat_B
- Habitat_I
infected Habitat_I
human Habitat_I
blood Habitat_I
monocyte Habitat_I
- Habitat_I
derived Habitat_I
DCs Habitat_I
, O
indicating O
that O
reduction O
of O
annexin1 O
is O
a O
critical O
mechanism O
for O
immune O
evasion O
by O
Mtb Bacteria_B
. O

Collectively O
, O
these O
data O
indicate O
that O
annexin1 O
is O
essential O
in O
immunity O
to O
Mtb Bacteria_B
infection O
and O
mediates O
the O
power O
of O
DC Habitat_B
efferocytosis O
and O
cross O
- O
presentation O
. O

Natural O
history O
of O
colonization O
with O
methicillin O
- O
resistant O
Staphylococcus Bacteria_B
aureus Bacteria_I
( O
MRSA Bacteria_B
) O
and O
vancomycin O
- O
resistant O
Enterococcus Bacteria_B
( O
VRE Bacteria_B
) O
: O
a O
systematic O
review O
. O

No O
published O
systematic O
reviews O
have O
assessed O
the O
natural O
history O
of O
colonization O
with O
methicillin O
- O
resistant O
Staphylococcus Bacteria_B
aureus Bacteria_I
( O
MRSA Bacteria_B
) O
or O
vancomycin O
- O
resistant O
Enterococcus Bacteria_B
( O
VRE Bacteria_B
) O
. O

Time O
to O
clearance O
of O
colonization O
has O
important O
implications O
for O
patient Habitat_B
care O
and O
infection O
control O
policy O
. O

We O
performed O
parallel O
searches O
in O
OVID O
Medline O
for O
studies O
that O
reported O
the O
time O
to O
documented O
clearance O
of O
MRSA Bacteria_B
and O
VRE Bacteria_B
colonization O
in O
the O
absence O
of O
treatment O
, O
published O
between O
January O
1990 O
and O
July O
2012 O
. O

For O
MRSA Bacteria_B
, O
we O
screened O
982 O
articles O
, O
identified O
16 O
eligible O
studies O
( O
13 O
observational O
studies O
and O
3 O
randomized O
controlled O
trials O
) O
, O
for O
a O
total O
of O
1 O
, O
804 O
non O
- O
duplicated O
subjects O
. O

For O
VRE Bacteria_B
, O
we O
screened O
284 O
articles O
, O
identified O
13 O
eligible O
studies O
( O
12 O
observational O
studies O
and O
1 O
randomized O
controlled O
trial O
) O
, O
for O
a O
total O
of O
1 O
, O
936 O
non O
- O
duplicated O
subjects O
. O

Studies O
reported O
varying O
definitions O
of O
clearance O
of O
colonization O
; O
no O
study O
reported O
time O
of O
initial O
colonization O
. O

Studies O
varied O
in O
the O
frequency O
of O
sampling O
, O
assays O
used O
for O
sampling O
, O
and O
follow O
- O
up O
period O
. O

The O
median O
duration O
of O
total O
follow O
- O
up O
was O
38 O
  O
weeks O
for O
MRSA Bacteria_B
and O
25 O
  O
weeks O
for O
VRE Bacteria_B
. O

Based O
on O
pooled O
analyses O
, O
the O
model O
- O
estimated O
median O
time O
to O
clearance O
was O
88 O
  O
weeks O
after O
documented O
colonization O
for O
MRSA Bacteria_B
- O
colonized O
patients Habitat_B
and O
26 O
  O
weeks O
for O
VRE Bacteria_B
- O
colonized O
patients Habitat_B
. O

In O
a O
secondary O
analysis O
, O
clearance O
rates O
for O
MRSA Bacteria_B
and O
VRE Bacteria_B
were O
compared O
by O
restricting O
the O
duration O
of O
follow O
- O
up O
for O
the O
MRSA Bacteria_B
studies O
to O
the O
maximum O
observed O
time O
point O
for O
VRE Bacteria_B
studies O
( O
43 O
  O
weeks O
) O
. O

With O
this O
restriction O
, O
the O
model O
- O
fitted O
median O
time O
to O
documented O
clearance O
for O
MRSA Bacteria_B
would O
occur O
at O
41 O
  O
weeks O
after O
documented O
colonization O
, O
demonstrating O
the O
sensitivity O
of O
the O
pooled O
estimate O
to O
length O
of O
study O
follow O
- O
up O
. O

Few O
available O
studies O
report O
the O
natural O
history O
of O
MRSA Bacteria_B
and O
VRE Bacteria_B
colonization O
. O

Lack O
of O
a O
consistent O
definition O
of O
clearance O
, O
uncertainty O
regarding O
the O
time O
of O
initial O
colonization O
, O
variation O
in O
frequency O
of O
sampling O
for O
persistent O
colonization O
, O
assays O
employed O
and O
variation O
in O
duration O
of O
follow O
- O
up O
are O
limitations O
of O
the O
existing O
published O
literature O
. O

The O
heterogeneity O
of O
study O
characteristics O
limits O
interpretation O
of O
pooled O
estimates O
of O
time O
to O
clearance O
, O
however O
, O
studies O
included O
in O
this O
review O
suggest O
an O
increase O
in O
documented O
clearance O
over O
time O
, O
a O
result O
which O
is O
sensitive O
to O
duration O
of O
follow O
- O
up O
. O

Identification O
of O
a O
novel O
glycoprotein O
- O
binding O
activity O
in O
Streptococcus Bacteria_B
pyogenes Bacteria_I
regulated O
by O
the O
mga O
gene O
. O

The O
interaction O
between O
Streptococcus Bacteria_B
pyogenes Bacteria_I
and O
the O
host Habitat_B
cell Habitat_I
surface O
is O
not O
completely O
understood O
. O

Characterization O
of O
the O
adhesion O
mechanisms O
of O
the O
bacterium O
to O
the O
host Habitat_B
cell Habitat_I
surface O
is O
needed O
in O
order O
to O
develop O
new O
vaccines Habitat_B
and O
anti O
- O
adhesion O
drugs O
. O

The O
presence O
of O
glycoprotein O
- O
binding O
activities O
among O
streptococcal Bacteria_B
strains O
was O
investigated O
. O

An O
activity O
binding O
to O
thyroglobulin O
, O
fetuin O
, O
asialofetuin O
and O
mucin O
but O
not O
non O
- O
glycosylated O
proteins O
was O
found O
to O
be O
present O
in O
the O
majority O
of O
the O
S Bacteria_B
. Bacteria_I
pyogenes Bacteria_I
strains O
studied O
. O

Cross O
- O
inhibition O
experiments O
suggested O
that O
the O
glycoproteins O
share O
a O
common O
structure O
recognized O
by O
the O
bacteria O
. O

The O
glycoprotein O
- O
binding O
activity O
was O
found O
to O
be O
proteinaceous O
, O
tightly O
attached O
to O
the O
bacterial O
surface O
and O
it O
also O
mediated O
the O
adherence O
of O
bacteria O
to O
solid O
surfaces O
coated O
with O
glycoproteins O
. O

The O
activity O
was O
found O
by O
transposon O
mutagenesis O
and O
complementation O
to O
be O
regulated O
by O
the O
multiple O
- O
gene O
regulator O
Mga O
, O
which O
has O
been O
implicated O
as O
a O
regulator O
of O
S Bacteria_B
. Bacteria_I
pyogenes Bacteria_I
virulence O
factors O
. O

